CA2560294A1 - Methods and devices for relieving stress - Google Patents

Methods and devices for relieving stress Download PDF

Info

Publication number
CA2560294A1
CA2560294A1 CA002560294A CA2560294A CA2560294A1 CA 2560294 A1 CA2560294 A1 CA 2560294A1 CA 002560294 A CA002560294 A CA 002560294A CA 2560294 A CA2560294 A CA 2560294A CA 2560294 A1 CA2560294 A1 CA 2560294A1
Authority
CA
Canada
Prior art keywords
heart rate
wave
interval
rate related
rsa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002560294A
Other languages
French (fr)
Other versions
CA2560294C (en
Inventor
Michael Wood
Adam Forbes
Kirstin Rhys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips RS North America LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2560294A1 publication Critical patent/CA2560294A1/en
Application granted granted Critical
Publication of CA2560294C publication Critical patent/CA2560294C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02405Determining heart rate variability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/486Bio-feedback
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/288Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for artificial respiration or heart massage
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816Measuring devices for examining respiratory frequency

Abstract

Easy to use, cost-effective methods and devices for evaluating and treating stress and thereby disorders caused or exacerbated by stress are provided.
More particularly methods and devices for identifying RSA waves during respiration which provide a subject with near real-time RSA .wave information are provided. This information can be used in biofeedback settings to assist subjects in reducing levels of stress by achieving rhythmic breathing patterns.

Description

Methods and Devices for Relieving Stress Related Application This application claims priority to and benefit from co-pending U.S.
Provisional Application No. 60/554,211, filed March 18, 2004 and is incorporated herein.
Field of Invention The present invention relates to methods and devices for evaluating and treating stress and stress-related disorders. More particularly the present invention relates to biofeedback devices and methods for increasing parasympathetic nerve activity by providing information on respiratory sinus arrhythmia patterns.
Background Information Despite the existence of many stress reduction products and services, stress and stress-related disorders still result in staggering economic and non-economic costs. It has been estimated that in the United States alone, job stress accounts for nearly $300 billion annually in terms of productivity, absenteeism and turnover. Over and above the direct work-related costs, attempts at treating stress and stress related disorders accounted for over $17 billion in anti-depression and anti-anxiety drugs in 2002. An ever upward trend in annual costs of such pharmacological treatments continues.
In addition, stress results in significant but incalculable costs due to concomitant health problems stemming directly or indirectly from underlying stress disorders. For example, studies have shown that people experiencing stress are more susceptible to viral and non-viral diseases. A common and well-known example of this is the relationship between stress and respiratory infections. Moreover, those suffering from an illness take longer to recover if suffering from stress as well.
Chronic stress can impair both the balance of the autonomic nervous system (ANS) and the efficacy of the ANS, resulting in a myriad of stress related disorders. Impairment of the ANS results in degenerative disease and premature death. For example, a clinical study examined a single two minute measurement of the ANS from 14,025 healthy men and women between the ages of 45 and 64. After eight years, those with a lower measurement had a much greater incidence of disease and death. Three other studies (US, Denmark, and Finland) have also examined ANS function as it relates to "all cause mortality". In each study, low ANS function preceded and predicted illness and death. Literally hundreds of other studies have examined ANS function as it relates to individual illnesses such as heart disease, diabetes, and stroke. For example, the British government commissioned a study on the ANS function and heart disease. Those with the lowest ANS function had more than a 1,000% increase in mortality rate from heart attacks. Non-economic costs of stress are also significant and include the harmful effects on relationships with family, friends, neighbors and co-workers.
The human body's reaction to stress, called the "stress response," involves two basic systems: the autonomic nervous system and the endocrine system. The ANS
generally innervates smooth muscles of internal organs and consists of sympathetic and parasympathetic divisions. In simple terms, the sympathetic division is responsible for mobilizing energy to respond to emergencies ("fight or flight"), express emotions or perform strenuous activities, while the parasympathetic division acts to exert a calming influence and thereby balance the sympathetic system.
The endocrine system is also involved in stress-related processes. In particular, the hypothalamic-pituitary adrenal (HPA) axis plays a major role in the endocrine system's stress response. The hypothalamus secretes peptide hormones to stimulate the pituitary glands which in turn secrete its own hormones to stimulate other endocrine glands.
The adrenal glands secrete cortisol which regulates metabolism and the production of energy and regulates responses in the sympathetic and parasympathetic branches of the autonomic nervous system. Cortisol levels are directly related to the degree of an individual's stress response.
In the early 1970's Dr. Herbert Benson documented the existence of a neurological and physiological state opposite of the "stress response." This state, called the "relaxation response," has been verified by other clinical investigators. From an autonomic nervous system perspective, the stress response is characterized by high activity of the sympathetic branch while the relaxation response is characterized by high activity of the parasympathetic branch. Inducing the relaxation response by definition interrupts an activated stress response.
Therefore, frequent activation of the relaxation response can prevent stressors from creating on-going (i.e., chronic) stress. Also, frequent activation of the relaxation response has been shown to reverse much of the damage, including hypertension, caused by previously encountered chronic stress.
The interaction of the two branches of the autonomic nervous system (sympathetic and parasympathetic) can be characterized by examining the small changes in the time occurring between each consecutive heart beat. When an individual is at rest, variation in the beat to beat time is caused by the parasympathetic branch. This variation will increase and decrease according to an individual's respiratory pattern. During inspiration, the parasympathetic branch is inhibited, and the heart rate will begin to rise.
During expiration, the parasympathetic branch engages and lowers the heart rate. This relationship between the changing heart rate and breathing is called respiratory sinus arrhythmia (RSA). RSA
measurements are mathematical calculations of the degree to which the heart rate rises and falls. When the rise and fall are greater, then the activity of the parasympathetic nervous system is greater. In other words, greater RSA indicates greater parasympathetic activity. As stated previously, a sufficient increase in parasympathetic activity shifts the body into the relaxation response thereby interrupting any pre-existing stress response.

Many attempts have been made to activate the relaxation response to treat or control stress, including both invasive and non-invasive techniques and procedures.
For example, acupuncture, prescription and non prescription pharmacological treatment, and psychotherapy have all been used in attempts to relieve or control stress. However, each of these therapies involves significant costs in money and time. Moreover, the effectiveness of these treatments is often less than complete and is sometimes nearly non-existent.
Effectiveness often is difficult to evaluate and is many times only temporary. In addition, pharmacological treatments frequently have undesirable side effects and some may even have addiction risks.
Also, even with all the available alternatives, stress still is responsible (either directly or indirectly) for more than 80% of doctor's visits.
Accordingly, a clear need exists for methods and devices for evaluating and treating stress, wherein such methods and devices are effective, non-invasive, simple to use and inexpensive. In addition, a clear need exists for methods and devices which do not have unwanted side effects or create addiction risks.
Summary of Invention The present invention provides easy to use, cost-effective methods and devices for evaluating and treating stress and thereby disorders caused or exacerbated by stress. More particularly, the present invention provides methods and devices for identifying individual RSA waves and providing a subject with near real-time RSA wave information.
This information can be used, for example, in biofeedback settings to assist subjects in reducing levels of stress and achieving rhythmic breathing.
Accordingly, one exemplary embodiment of the present invention provides portable, handheld biofeedback devices for reducing stress in human subjects.

Another exemplary embodiment of the present invention provides portable, handheld biofeedback devices which contain a photoplethysmograph ("PPG") sensor and a display screen to provide subjects with near real-time information on their RSA waves.
A further exemplary embodiment of the present invention provides a methods and devices for training subjects to reduce levels of stress by achieving a respiration frequency of close to 6 breaths per minute.
Yet another exemplary embodiment of the present invention provides methods for detecting and correcting erroneous data relating to RSA waves and devices which utilize such methods.
Another exemplary embodiment of the present invention provides methods for adjusting scaling on a display screen of portable biofeedback devices and devices which utilize such methods.
Still another embodiment of the present invention identifies respiration patterns including depth, rate and volume by analyzing RSA waves and provides a display of same.
Brief Description of Drawings Figure 1 illustrates a typical heart rate variability (HRV) pattern caused by respiratory sinus arrhythmia (RSA).
Figure 2 illustrates an exemplary series of RSA waves and identifies several pulse peaks.
Figure 3 illustrates an exemplary series of RSA waves and calculates the interbeat interval times (IBI) between successive pulse peaks.
Figures 4a-d identify, respectively, a representative top point, bottom point, ascending transition point and descending transition point.
Figure S illustrates representative consecutive ascending and descending transition points.
Figure 6 illustrates an exemplary method for identifying a top point.
Figure 7 illustrates an exemplary method for identifying a bottom point.

Figures 8(a)-(b) depict an exemplary process flow for an exemplary procedure for finding RSA waves within a data set according to an exemplary embodiment of the present invention;
Figure 9 illustrates an exemplary procedure for identifying RSA waves within a data set.
Figure 10 illustrates an exemplary double top wave.
Figure 11 illustrates an exemplary method for correcting data from a representative double top wave.
Figure 12 illustrates an exemplary display of a stress meter.
Figure 13 illustrates an exemplary embodiment of a device in accordance with the present invention and identifies a potential location for a power switch.
Figure 14 illustrates a representative location for a PPG sensor which can collect data from a subject's finger.
Figure 15a-b illustrates alternate methods for a subject to hold an exemplary device while the subject's finger is in the PPG sensor.
Figure 16 illustrates an exemplary display of a countdown meter.
Figure 17 illustrates an exemplary display of a representative average pulse rate as well as a pulse rate over time.
Figure 18 illustrates an exemplary display of an error message.
Figure 19 illustrates an exemplary embodiment of a countdown timer.
Figure 20 provides a representative illustration of RSA waves of a subject whose breathing has slowed over time.
Figure 2lprovides a representative illustration of RSA waves of a subject who has taken deeper breaths over time.
Figure 22 illustrates a representative RSA pattern consistent with rhythmic breathing.
Figure 23 provides a representative display of a subject with a wave frequency of six.
Figure 24 provides another representative display of a subject with a wave frequency of six.

Figure 25 illustrates an exemplary display of a session score for a subject.
Figure 26 illustrates an exemplary display of a subject whose depth of breathing has increased and is generated relatively large waves with a duration of about 10 seconds each.
Figure 27 illustrates a representative location for a guided breathing switch for activating a guided breathing function in exemplary devices of the present invention.
Figure 28a-b illustrate an exemplary display for guided breathing with a breathing bar that increases to guide inhalation and decreases to guide exhalation.
Figure 29 illustrates an exemplary display of a session summary screen.
Figure 30 illustrates an alternate form factor for exemplary devices of the present invention.
Figure 31a-b illustrate, respectively, a display having sufficient size to show both accurate data and erroneous data and a display of a small, portable device in which only the erroneous data is descernible.
Figure 32 illustrates a series of representative pulse peaks.
Figure 33a-b illustrate, respectively, a representative false positive pulse peak and a representative false negative pulse peak.
Figure 34 depicts an exemplary process flow for an exemplary error correction method employed during a representative error correction mode.
Figure 35 illustrates representative wave features which may be used to determine when a subject has achieved rhythmic breathing.
Figures 36 - 37 depict an exemplary process flow for an exemplary top level procedure for interacting with a user according to an exemplary embodiment of the present invention.
Figures 38 - 42 depict an exemplary process flow for an exemplary procedure for processing a detected pulse according to an exemplary embodiment of the present invention.

Figures 43 - 45 depict an exemplary process flow for an exemplary procedure for error correction for a sequence of detected pulses according to an exemplary embodiment of the present invention.
Figures 46 - 47 depict an exemplary process flow for an exemplary procedure for error detection for a sequence of detected pulses according to an exemplary embodiment of the present invention.
Figures 48 depicts an exemplary process flow for an exemplary procedure for initializing a range for detected pulses according to an exemplary embodiment of the present invention.
Figures 49 - 50 depict an exemplary process flow for an exemplary procedure for processing RSA waves within a sequence of detected pulses according to an exemplary embodiment of the present invention.
Figures 51 - 53 depict an exemplary process flow for an exemplary procedure for processing RSA wavelengths within a sequence of detected pulses to determine a stress level for a user according to an exemplary embodiment of the present invention.
Figure 54 depicts an exemplary process flow for an exemplary procedure for assigning wavelengths to RSA waves according to an exemplary embodiment of the present invention.
Figure 55 depicts an exemplary system in which a software process can be implemented according to an exemplary embodiment of the present invention .
Detailed Description Studies have shown that controlled respiration can shift the balance of the sympathetic and parasympathetic branches. Three specific respiratory components interactively determine the amount of parasympathetic innervation. These three components include frequency, tidal volume, and expiration/inspiration ratio. In general, parasympathetic activity can be increased by reducing breath frequency, increasing tidal volume, and/or increasing the expiration/inspiration ratio. Thus, altering these three variables has the potential to increase parasympathetic activity enough to effectively elicit the relaxation response non-invasively, simply, inexpensively, and without negative side-effects.
Generally speaking, biofeedback methods and devices involve training processes which allow subjects to facilitate changes in behavior or activity in order to improve or maintain one or more physiological functions. Over time, a subject can be trained with biofeedback methods and devices to exercise greater control over these functions. In contrast to other forms of therapy in which treatment is imposed upon the subject, biofeedback methods and devices allow the subject to gradually integrate the training processes into almost automatic responses.
The present invention relates to methods and devices which can provide biofeedback information and training for subjects suffering from stress and stress-related disorders. Such biofeedback information and training may be based on an analysis of respiratory sinus arrhythmia patterns and breathing that can affect such patterns.
There are no known methods for identifying individual RSA waves during spontaneous breathing using only the RSA data set. In order to correlate RSA
waves with respiration, usually heart rate and respiration rate information is collected and mapped separately. One aspect of the present invention includes the identification of the individual waves within a RSA data set. A further aspect of the present invention includes the use of such wave patterns to provide subjects with near real-time respiratory feedback information based on heart rate data. Means for decreasing or adequately controlling stress levels also can be provided based on the wave pattern analysis and respiratory feedback.
Wave Pattern Identification In one exemplary embodiment of the present invention, identification and analysis of respiratory sinus arrhythmia wave patterns begins by measuring a subject's pulse rate on a beat to beat basis. It is well established in medical literature that human heart rates, and therefore pulse rates, continually fluctuate up and down-in a wave like manner (Fig 1). These waves are known as heart rate variability (HRV) waves. When a person is physically still and resting, the HRV waves are related to a person's respiration. These resting HRV waves are medically known as respiratory sinus arrhythmia or RSA waves, as the size and shape of these waves is related to the rate, rhythm, and depth of a person's breathing.
As long as a person is breathing between 4 to 15 breaths per minute, the frequency of the waves will essentially match the frequency of respiration. Most individuals breathe within this range, but even when a person is breathing outside this range, the wave frequency still provides a close approximation to the respiration frequency.
While the correlation between waves and breathing has been well established in the medical literature by visual analysis, no automated method exists to identify individual waves within a heart beat data set. An exemplary embodiment of the present invention includes a novel method of identifying each individual wave for a heart beat data set.
For example, the amount of time (in milliseconds) between two consecutive pulse peaks (the peak-to-peak time) is called the pp interval (pp) (Fig 2). In an exemplary embodiment of the present invention, a device records successive pp intervals.
The description of pp interval points also applies to rr intervals (the interval between consecutive R waves in an electrocardiograph or ECG), any derivative of pp intervals such as the pulse rate points, and any derivative of rr intervals such as heart rate.
Collectively, these intervals may be referred to as "heart rate related intervals." Furthermore, the same method of extracting RSA waves from pp intervals can be directly applied to these other points as well.
Preferred embodiments of the present invention, however, parse waves within pp interval data sets.
The pulse rate of each recorded pp interval (60,000 / pp) may be displayed on the screen each time a new pulse peak is encountered. The absolute time difference between successive pp intervals (absolute (pp[n] - pp[n-1])) is called the interbeat interval time (IBI) (Fig. 3). An aspect of the present invention uses the pp interval times to identify individual RSA waves. The methods described herein may be used for both spontaneous and guided breathing.
Each p-p may be categorized by examining its relationship to the p-p immediately before it (the previous pp) and the p-p immediately after it (the next p-p). A
p-p may be considered a top point (tp) if the previous p-p is equal to or less than it and the next p-p is equal to or less than it as well (Fig. 4a). A p-p may be considered a bottom point (bp) if the previous p-p is equal to or greater then it and the next p-p is equal to or greater than it as well (Fig. 4b). A p-p may be considered an ascending transition point (at) if the previous p-p is less than it and the next p-p is greater than it (Fig. 4c). A p-p may be considered a descending transition point (dt) if the previous p-p is greater than it and the next p-p is less than it (Fig. 4d). Thus, a p-p may be categorized as either a top point (tp), bottom point (bp), ascending transition point (at), or descending transition point (dt). The "term transition point" can be used to refer to both ascending and descending transition points when it is not qualified with the words "ascending" or "descending". Consecutive transition points refers to a series of consecutive ascending transition points or descending transition points (Fig. 5).
The term "top level" may be used to refer to the-relative height of the top point. The level of a top point may be computed as follows. L = the number of consecutive points immediately to the left of the top point that are less than or equal to the top point. R = the number of consecutive points immediately to the right of the top point that are less than or equal to the top point. If L < R, then the top level is equal to L, otherwise the level of the top is equal to R. Fig. 37/Fig. 6 illustrates, using three examples, how the top point level may be categorized.

The term "bottom level" may be used to refer to.the relative height of the bottom point. The level of a bottom point may be computed as follows. L = the number of consecutive points immediately to the left of the bottom point that are greater than or equal to the bottom point. R = the number of consecutive points immediately to the right of the bottom point that are greater than or equal to the bottom point. If L < R then the bottom level is equal to L otherwise the level of the bottom is equal to R. Fig. 7 illustrates, using three examples, how the bottom point level may be categorized.
Figs. 8(a)-(b) provide an exemplary flowchart which illustrates an exemplary procedure for finding the RSA waves within a data set while Fig. 9 illustrates how this procedure may be applied. In an exemplary embodiment of the present invention, the first step is to locate the highest number of consecutive transition points (ctp) in the data set. In Fig. 9 the highest number of consecutive transition points begins at point 1.
There are 2 consecutive transition points. The wave depth is equal to the number of these transition points. Thus, the wave depth in this example is 2. In preferred embodiments, if the wave depth is greater than 4, the wave depth value is adjusted down to 4.
The next step is to locate the bottom point to the right of the consecutive transition points where the bottom level is equal to or greater than the wave depth. This is the right valley point (v2) of the RSA wave. In the example in F.ig. 9, bottom point no.
8 has a level of 3, which is greater than the wave depth. The next step is to locate the bottom point to the right of the consecutive transition points where the bottom level is equal to or greater than the wave depth. This is the left valley point (v1) of the RSA wave. In the example provided in Fig. 9, bottom point no. 0 has a level 4, which is greater than the wave length. The next step is to find the highest point between the left valley point and the right valley point. This is the peak (p) of the RSA wave. In the example in Fig. 40/Fig. 9, point 6 is the highest point between the two valley points. All data from the left valley point (v1) to the right valley point (v2) is considered processed data. The same procedure is repeated on the remaining unprocessed data until all possible waves have been identified.
There are a number of variations in the method described above which should be considered within the scope of the present invention. For example, a similar method could be used to find peaks on each side of a transition point series. The valley between two peak points would therefore be the lowest point between the two peaks. Also, wave depth may be based on the absolute number of transition points or a derived number based upon the number of transition points (e.g., number of transition points x 75%). Also, the v1 point could be identified before the v2 point.
In preferred embodiments, the wave parsing method discussed above is used each time a new bottom level 4 point is identified. Thus, devices according to exemplary embodiments of the present invention "look" for RSA waves between bottom level 4 points.
In other exemplary embodiments, devices may be configured to "look" for RSA
waves after each point, or after a certain period of time elapses (every 30 seconds for example), etc.
Exemplary embodiments use bottom level 4 points because they have a very high probability of delineating RSA waves. That is, they have a high probability of being valley points (v1, v2) of RSA waves.
There are two instances where the basic RSA wave parsing methods described above may inaccurately describe an RSA wave. One may occur when a double top wave is encountered. Double top waves may be formed when a person waits a long time to inhale after he or she has already exhaled. Another may occur when double bottom waves are formed. Double bottom waves may be formed when a person holds his breath for a long time after inhaling. Double tops are easily identified by examining the ratios of lengths of the two waves (Fig. 10). When (pl-v2) is much smaller than (p1 - v1), and (p2 - v2) is much smaller than (p2 - v3), and (p 1 -v2) is very close to (p2 - v3) then a double top has occurred. In preferred embodiments, double tops may be defined as situations where: ((p1 -v2) / (p1 -v2)) < 0.50 and ((p2 - v2) / (p2 - v3)) < 0.50 and ((p 1 - v 1 ) / (p2 - v3)) > 0.75. Double bottoms may be defined as the inverse of double tops.
Whenever double tops or double bottoms are produced from the basic parsing method, the two waves forming the pattern may be merged together into one wave. Point v1 is the v1 of the new wave. Point v3 becomes the v2 of the new wave. The highest value between v1 and v3 is the peak point ofthe new wave. This is illustrated by Fig. I I .
Use of RSA Waves to Analyze and Reduce Stress Exemplary embodiments of the present invention can use the RSA wave information described above to assess the user's level of mental stress. This mental stress measurement may be presented in devices as a stress meter (Fig. 12(5)). For example, when a person is stressed, breathing usually becomes rapid and irregular, relative to a non-stressed state. This rapid, irregular breathing can cause the formation of short, choppy RSA waves.
Methods and devices according to the present invention can be used to determine the user's stress level by determining how far the user's average wavelengths deviate from a level that represents a relaxed state. Such methods and devices also may compute how irregular (arrhythmic) the user's waves are. These two assessments may be used individually or combined into a single value to indicate the overall stress level.
Studies have demonstrated that when people are profoundly relaxed (such as in a state of deep meditation), they tend to breathe in a steady rhythm at approximately 6 breaths per minute. Such rhythmic breathing causes the RSA wavelengths to become entrained on the breathing frequency. Thus, rhythmic breathing at 6 breaths per minute will result in a series of RSA waves having wavelengths of 10 seconds. Thus, exemplary embodiments of the present invention use wavelengths of 10 seconds as the relaxation threshold when assessing the user's stress level. Exemplary embodiments also include methods and devices which compute the average wavelength of the last five waves to determine how far the average is, proportionally, from 10 seconds. This is one example of a "wavelength score".
Arrhythmic waves may be quantified using a number of standard variance formulas.
Exemplary embodiments of the present invention use the sum of the differences of each consecutive wavelength in the last five waves to compute a "variance score".
Exemplary embodiments also can use the sum of the differences between successive wavelengths and may use a rank order weighted averaging so that the variance of the most recent waves count more. The stress level in an exemplary embodiment of the present invention uses 70% of the "wavelength score" + 30% of the "variance score". The user's stress level can be recalculated each time a new RSA wave is identified.
Stress can cause a variety of RSA wave behaviors: decreased peak to peak times, increased peak to peak frequency, decreased~wavelength, increased wave frequency, decreased amplitude, irregular wavelengths, irregular wave frequencies, irregular amplitudes, irregular peak to peak times, irregular peak to peak frequencies, irregular peak placements or decreased variation. Any one of the preceding variables, or any combinations thereof, can be applied to RSA waves and used as an indicator of the level of stress.
Identifying individual RSA waves and using any of the preceding variables alone, in combination with each other, and/or in combination with other variables,.to evaluate stress is within the scope of the present invention and has not been described in the prior art.
In addition to using the identified RSA waves for determining stress levels, devices and methods according to exemplary embodiments of the present invention can also use RSA
wave information to determine and display both average heart rate and wave frequency. The average of all the pulse rates in the last wave may be used to assess average heart rate. For example, each time a new RSA wave is identified, the average of the pulse rates may be computed and the heart rate may be updated. The wave frequency display also may be updated every time that a new RSA wave is identified. Exemplary embodiments can express frequency relative to waves (breaths) per minute. In exemplary embodiments the wave frequency and heart rate may be rounded to the nearest integer.
Exemplary Device The description below relates to a particular exemplary embodiment of the present invention in the form of a device which may be used to evaluate stress in humans. In this exemplary embodiment, RSA waves may be identified as described above and used to provide biofeedback to a user. In addition to the particular exemplary embodiment described below, it should be appreciated that other methods and devices are intended to be within the scope of the present invention. Alternative embodiments are occasionally described under this section. Where alternative embodiments are not explicitly described, it is not the intention of applicants to limit the present invention to the exact description provided in this section. The full scope of the present invention is based on the disclosure in the specification as a whole.
The present invention includes, for example, a battery powered handheld portable device including a PPG sensor, a display screen, control buttons, and a power button (Fig.
13). The user can turn on the device by pressing a power button. If the device is being used in a dark room, the user can turn on backlighting by pressing the power button a second time and keeping it pressed for a few seconds. Soon after the device has been powered on, it prompts the user to insert a finger into the finger sensor (/Fig. 14). The user then gently holds the device with a finger resting on top of the sensor throughout the entire session. The device can be comfortably held vertically, resting on the thumb (Fig. 15a) or at an angle, resting on the curled fingers of the hand holding it (Fig. 1 Sb).
Once the finger has been inserted into the finger sensor, the device then begins to calibrate the PPG sensor. A countdown meter marks the amount of time required for the calibration (Fig. 16). After the PPG sensor is calibrated, the device uses the PPG sensor to detect each pulse of blood in the finger. The resulting pulse rate (60,000 /
number of milliseconds between two consecutive pulse peaks) is then plotted on the screen on a pulse by pulse basis (Fig. 17(2)). The display also shows the user his average pulse rate (Fig. 17(1)).
PPG sensors can be very sensitive to finger pressure. That is, if the user is squeezing the device, the resulting finger pressure may prevent the device from gathering accurate pulse rate information. Whenever the user applies too much pressure, the device will display an error message alerting the user to stop squeezing the device and start to relax his finger (Fig.
18). As soon as the user has successfully relaxed his finger, he is then returned to the pulse rate display screen.
When the device identifies a new RSA wave, it uses the wave information to determine and display five things: the frequency of the last wave, the average pulse rate of all the pulse points in the wave, the session score, the remaining session time and the stress index - how much mental stress the user is currently experiencing (Fig. 12).
The device updates the session countdown clock after every RSA wave has been identified. An alternative exemplary embodiment could include a session countdown clock that decrements on a regular basis (e.g., once per second, once every fifteen seconds, etc.). In this exemplary embodiment, the device updates after each RSA wave to avoid unconscious associations being made between the clock and the desired behavior. In other words, if the clock counted down on a per second basis, the user could consciously or unconsciously use the seconds as a guide to breathing at the rate of 6 breaths per minute. Such an association may prevent the user from unconsciously learning how to breathe at 6 breaths per minute whenever becoming stressed. If the user consciously (or even unconsciously) uses the clock, he or she may always be dependent on the device. However, by updating the clock based upon every wave, such a potential situation is not only avoided, but the clock can reinforce the learning. The user will see the exact number of seconds of each breath by the amount that the clock decrements. If the clock were to decrement more slowly (e.g., once every 30 seconds), the potential for unconscious associations between time and desired behavior would be avoided. However, in such an alternative implementation, the clock would not be reinforcing the learning.
In this exemplary embodiment, the session countdown timer begins to decrement once the first wave is identified and data is displayed (Fig. 19). However, alternative embodiments could begin decrementing the counter when the user begins to breathe rhythmically, or only when they good waves are achieved (e.g., waves with a frequency less than six), or only while the user is practicing rhythmic breathing. Another alternative is to not decrement the counter when the breathe button is being used and guidance is being provided.
Users can alter the behavior of the waves, and therefore their calculated stress level, by changing their breathing pattern. As the user slows down his rate of breathing, the wavelengths increase and the amplitude of the waves increases as well (Fig.
20). When a person breathes more deeply, the amplitude of the waves becomes even larger (Fig. 21).
When a person breathes rhythmically at a steady rate, the wavelengths entrain on the breathing rate (Fig. 22).
The first step in using the device to relax is.to inhale deeply and then slowly let the air out, extending exhalation. This will cause the wave lengths to become longer and therefore the frequency of the waves to decrease. The user continues to inhale deeply and to slow exhalation even more until the wave frequency drops to 6 (Fig. 16/Fig. 23). If the wave frequency drops below six, then the user will need to breathe a little faster -that is, not exhale quite as long next time.
Once the user has reduced the wave frequency to 6, he or she continues breathing at the same rate and rhythm that produced a frequency of 6. If the user's breathing rate increases, the frequency will increase, indicating that his next breath needs to have a longer exhalation. If the user's breathing rate becomes too slow, the frequency will drop below 6;
indicating that the exhalation of the next breath needs to be a little faster.
By paying attention to the wave frequency number, a user can quickly fill the screen with rhythmic waves that are seconds in length (Fig. 24) corresponding to a frequency of 6 respiration cycles per minute.
The session score is calculated and displayed after each RSA wave is identified. The score is based upon how close the user is to achieving the desired behavior.
The user accumulates score points. Various methods for scoring the session may be used.
In certain embodiments, the user receives 3 points if the waves have a frequency of 6 or less. The user receives two points for wave frequencies of 7 or 8, one point for wave frequencies of 9 or 10 and no points for frequencies greater than 10. The-accumulated session score could be displayed numerically. Alternatively, each individual score could be displayed. Yet another alternative is to show the current score along side a set of the previous scores (either numerically or graphically). Preferred embodiments graphically display the current score and a set of the previous scores (Fig. 25). In this way, the user can tell when he is breathing rhythmically. When the score display is uniform, the user is breathing rhythmically.
Once the user has filled the screen with rhythmic waves, he should focus on inhaling a little more deeply, and exhaling a little more fully. That is, the user should try to inhale and exhale a greater volume of air (called tidal volume). As the user gently increases the depth of his breathing, the size of the waves will increase (Fig. 26). The user continues to fill the screen with large waves whose wavelengths are 10 seconds each until the session timer runs out. The user will then find that he has achieved a very deep and profound state of relaxation.
If a user has difficulty breathing deeply and rhythmically at a rate of 6 breaths per minute he can obtain guidance by activating a breathing guide function. (Fig.
27). As soon as the user presses the breathe button, a breathing guide appears on the display.
The user is instructed to inhale as the breathing bar rises (Fig. 21a/Fig. 28a) and exhale as the breathing bar descends (Fig. 21b/Fig. 28b). In exemplary embodiments, the breathing guide paces the user's breathing to 6 breaths per minute with, for example, a 1:2 ratio of inhale:exhale. In alternative embodiments, the breathing guide could be programmed to provide other rhythms (e.g., 1:3) at a ration close to 6 breaths per minute (e.g., 4-8/minute). The breathing guide remains active for one minute, automatically shutting off thereafter. By having a temporary, rather than constant, breathing guide, the user is encouraged to use the biofeedback protocol to achieve the six breaths per minute respiration pattern. If the user were to rely solely on the breathing guide, it would be much more difficult to learn how to achieve the pattern on his own. Thus, by weaning the user off the breathing guide, the user is able to use biofeedback to create unconscious learning. An alternative exemplary implementation could prompt the user to turn off the breathing pattern after a period of time has occurred.
Other breathing rates and rhythms may be used as well.
The device returns the user to the regular display after the breathing guide has been completed. The user then adjusts his breathing in the manner previously described to reduce the wave frequency down to 6, maintain rhythmic breathing, and increase the size ofthe waves by breathing more deeply. The user continues this process until the session timer reaches 0:00, at which time the session summary screen may be displayed (Fig.
29).
Several aspects of the present invention can be combined together to create a number of alternative exemplary embodiments. For example, the device can feature a meter that could be used as an amplitude feedback meter rather than a stress meter. The meter could further have a target bar. Thus, the device could graphically display how deeply a person is breathing so he could learn to take deeper breaths. If a target bar is used, users could try to breathe deeply enough with each breath to cause the meter to rise above the target bar. Any numerical or graphical feedback (visual or otherwise) of amplitude would be within the scope of this alternative embodiment.
Another alternative exemplary embodiment could use the wave information (e.g., wavelength, amplitude, and peak placement) to determine and provide feedback regarding the degree to which a user is following a prescribed breathing protocol (e.g., 6 breaths per minute with an inhale:exhale ratio of 1:3). Alternatively, the user could be given a breathing guide while being provided simultaneous auditory or visual feedback on how closely they are conforming to the guided breathing pattern. Furthermore, a target level could be displayed such that a user would be considered compliant if he were above the target level and non-compliant with the breathing protocol if he or she were below the level.
Alternative exemplary embodiments can use the variance of one or more wave parameters to detect rhythmic breathing. Then, the degree of rhythmic breathing can be visually displayed numerically, graphically, or in some other manner.
Optionally, audible feedback may be provided. For example, in an exemplary embodiment a tone can increase as the breathing becomes more arrhythmic and decrease as it became more rhythmic.
Alternatively, a single beep can indicate rhythmic breathing, a double beep can indicate near rhythmic breathing, and a triple beep could indicate arrhythmic breathing.
Naturally, any of the previously mentioned feedback techniques or derivatives of these techniques could be used independently, in combination with each other, in combination with other techniques, or in combination with both each other and other techniques. Such an implementation may be used to practice yoga style rhythmic breathing patterns. For example, if the yoga student were practicing rhythmic breathing at an inhale:hold:exhale ratio of 1:1:1, he or she could use the device to ensure that rhythmic breathing was being maintained.
In other embodiments of the present invention, a pre-programmed breathing guide can be provided on the device so the user could follow the breathing guide while receiving visual and/or auditory feedback on the rhythmicity of his breathing. Furthermore, the breathing guide could be programmable. Optionally, feedback can be provided not only on the rhythm of the breathing, but rate as well. For example, if the user wanted to practice breathing at a 1:1:1 ratio at 5 breaths per second, visual and/or auditory feedback can indicate the degree to which a user is breathing rhythmically at five breaths per minute. Breathing at another frequency and/or arrhythmically would reduce the score.
Another exemplary embodiment provides feedback on the depth of breathing.
During rhythmic breathing, a measurable phenomenon using aforementioned methods, the primary difference in wave amplitudes is the tidal volume (the depth of breathing).
Thus amplitude measurements could be used for visual and/or auditory feedback to indicate the depth of a person's breathing. As stated previously, deep breathing is a useful way of relieving stress.
Exemplary embodiments can provide feedback on a user's depth of breathing to assist teaching the user how to breathe deeply and to thereby relieve stress.
In short, exemplary embodiments of the present invention can provide auditory and/or visual feedback for the following: rate of breathing, rhythmicity of breathing, depth of breathing, breathing conformance to a prescribed rate/rhythm, and the like. An assessment can be made of each of these, alone or in any combination. Feedback can be provided on one or more of such assessments. Any implementation that identifies two or more RSA waves and derives rate, rhythm, depth, and/or conformance is within the scope of the present invention.
Exemplary Form Factor Exemplary embodiments of the present invention incorporate a number of additional features. One such feature is the design of the device form factor. Prior to the present invention, biofeedback programs used finger PPG sensors, ear PPG sensors, and/or heart rate ECG sensors that attached to a computer via a wire. Although PPG sensors are sensitive to movement and finger pressure, the prior art did not have to deal with the many artifacts created by movement or excessive pressure because the prior art finger PPG
sensors were often placed on tables or desks. In this situation, users could rest their hands and fingers on the desk which stabilized the hand and finger, thereby preventing excessive movement and finger pressure.
Since external wires are generally socially (and otherwise) unacceptable, an exemplary embodiment of the present invention integrates a PPG sensor directly into a portable device and eliminates external wires. As a result, devices according to exemplary embodiments of the present invention can be comfortably used in a public setting.
Integrating a PPG sensor into a portable device, however, requires an innovative form factor.
For example, since session times can range from 5 - 15 minutes, users of the device will be holding the device, without a stabilizing structure like a desk, for an extended period of time.
Accordingly, the present invention provides devices which can be comfortably gripped, while simultaneously al lowing the user to gently rest his finger on the finger sensor.
The present invention also provides form factors that provide comfort while minimizing artifacts caused by movement and pressure over extended periods of time (e.g., - 15 minutes). Two exemplary form factors accomplish these objectives. In the first, the finger sensor is on the top of the device near one of the edges.
Ergonomically, the height from the bottom of the device to the top may be between about I .S inches and about 3.5 inches and is preferably around 2.5 inches. This allows the device to be supported either by the thumb when held vertically (Fig. 15a), or supported by the curled fingers when tilted (Fig.
15b). In the second, the finger sensor is located on the rounded back of the device with the display on the front, allowing the device to rest, for example, in the palm of the hand during use (Fig. 30). The particularly preferred form factor is the first-described above which allows for the design of products with a scientific and medical look and feel.

Error Detection and Correction . .
While either form factor described above will minimize artifacts, the hardware form factor may not eliminate every possible artifact. Because there is no supporting structure such as a table or desk, the hand and finger will move at different times throughout the session. While the hardware will minimize artifacts, the remaining artifacts can be addressed by software in exemplary embodiments of the present invention. Also, the device not only detects when an error has occurred, but it also corrects the error.
In general, displays on small portable devices are much more sensitive to errors because such displays are very small compared to that of a desktop computer, for example.
When an error occurs on a desktop computer, the display has enough resolution to show both the accurate data and the error (Fig. 31a). On a small, portable device, however, one error can cause all the correct data to become indiscernible due to its low resolution (Fig. 31b).
Numerous statistical methods for detecting errors in a data stream exist in the state of the art. However, these methods require a large sampling of data before they provide a high degree of accuracy. As mentioned above, devices having small displays can be adversely affected by even a single error. Thus, errors should be detected quickly and accurately and.
then corrected. Devices according to an exemplary embodiment of the present invention implement a novel method of error detection and.correction that requires only a small amount of data (approximately 10 seconds) before it becomes highly accurate.
To facilitate further understanding of the error detection and correction methods of the present invention a brief explanation of how PPG sensors are used to obtain pulse information in ideal, error-free conditions is provided. PPG sensors detect the amount of blood pressure in the finger on a continual basis. Each time the heart beats, the corresponding pulse of blood results in a rapid increase in blood pressure in the finger, which then quickly subsides. The PPG sensor continually seeks to identify the time when the blood pressure peaks (Fig. 32). This is the pulse peak. As discussed previously, the amount of time (in milliseconds) between two consecutive pulse peaks is called the pp interval (pp) (Fig 2).
Devices according to the present invention can record each successive pp interval. The pulse rate of each recorded pp interval (60,000 / pp) can be displayed on the screen each time a new pulse peak is encountered. The absolute time difference between successive pp intervals (absolute (pp[n] - pp[n-1])) is called the interbeat interval time or IBI
(Fig. 3).
Two types of errors occur when the PPG sensor is attempting to correctly identify the next pulse peak. (Fig. 33) One type of error can occur when the PPG sensor incorrectly identifies an artifact as a pulse peak. That is, the PPG sensor determines that a pulse peak occurs where one does not actually exist. This type of error is called a false positive error.
The second type of error occurs when the PPG sensor does not identify a pulse peak that does exist. This is called a false negative error. Both false negatives and false positives result in large IBIs Error free data may or may not result in large IBIS. However, erroneous data always produces a large IBI. Thus, wherever there is an extended amount of consecutive data that does not contain a large IBI, one can safely assume that this data is free of errors. Where large IBIS occur, it may be due to an error or may be good data; the device will need to determine which is the case.
According to preferred exemplary embodiments of the present invention, the first step in the error detection strategy is to wait for a certain number of heart rate related intervals (e.g., 10 pp intervals) where every IBI time is less than 200ms. These data points are considered to be error free. The number of consecutive intervals can be less than 10 but needs to be at least 2, preferably at least 3 and even more preferably at least S. Another .
alternative is to wait for a set of consecutive data points where every IBI
time is less than 1/3 of the lowest heart rate related interval, such as a. pp interval, in the consecutive data set (e.g., consecutive pp intervals). The range of these data points can be computed. As used herein, "range" can refer to the absolute range (i.e., min pp to max pp), a derivation of the range (e.g.
((min pp - 10%) - (max pp + 10%)), or as a computed variation (e.g. mean deviation, standard deviation, etc.). Any appropriate mathematical description of the range can be used.
Preferred embodiments according to the present invention use min pp - ((max pp - min pp) x 25%) as the bottom of the range. The preferred embodiment uses max pp + ((max pp - min pp) x 25%) as the top of the range. The range may be derived from the entire data set or a subset of the data set.
Once the range has been established, each new p-p is tested to determine if it is "in range". In exemplary embodiments, a new pp value is considered "in range" if it is greater than the bottom value and less than the top value. However, "in range" also can refer to any mathematical determination of close proximity of the current p-p to the range as determined by the selected range calculation. For example, if the range was calculated using the standard deviation, "in range" could refer to the statistical determination that the current p-p has an 80% or higher probability of being within the computed variation.
As new pp intervals arrive, the new IBI also may be computed (absolute new pp -previous pp). The new IBI may be tested to determine if it is "large". In preferred embodiments, the device tests whether the IBI is greater than one half the bottom value of the range. If it is greater, the IBI is considered to be large. In other exemplary embodiments, the IBI time of the new pp interval minus the previous interval can be computed.
Other IBI times could be used instead, such as the 1BI of the new p-p compared to the average p-p of the last n number of pp intervals. Also, different implementations can use a different threshold for distinguishing large IBIS from non-large IBIs. According to embodiments of the present invention, any implementation can be used that uses the difference of pp intervals or the difference of a derivative of pp intervals (such as the average) in order to detect an error.

To summarize the above, when the device according to exemplary embodiments of the present invention begins, it may not enter error detection mode until 10 consecutive pp intervals are located where all the 1B1 times are less than 200ms. Then, the device can calculate the range of these pp intervals and initiates an error detection mode. In the error detection mode, the device can test each new pp to determine if it is "in range" and the device tests each new IBI to determine if it is "large". Any other suitable method of determining either or both of these two properties for use in error detection also is within the scope of the present invention.
If the next p-p is "in range" and the IBI is not "large", then the new p-p can be considered to be error-free. If the p-p is not "in range" and the IBI is not "large", the new p-p can be considered to be error-free and the range is recalculated to include the newly found pp value. If the new p-p is "in range" but the IBI is "large", the new p-p can be considered to be error-free. However, when the new p-p is "out of range" and the IBI is "large", then the new p-p can be considered to be the result of an error. Once an error has been detected, it should be corrected. Therefore, each time that an error is detected in error detection mode, the device changes to error correction mode. The device can remain in error correction mode until erroneous condition has been resolved.
Fig. 34 provides a flowchart showing an exemplary error correction methodology employed during an error correction mode. Error correction includes summing together each successive pp interval as it is identified until either the sum of the pp intervals is "in range" or the sum can be divided by an integer such that the result of the division is "in range". When the sum itself is "in range", all the pp intervals forming the sum can be combined together into a single value equal to the sum. When the sum divided by an integer is in range, the erroneous values can be replaced with n (where n = the integer denominator) number of values equal to the result of the division.

The following discussion provides examples of how errors may be corrected according to an exemplary embodiment of the present invention. For example, if the range is 600ms - 1,000 ms, and the erroneous pp interval time is 200 ms. The next pp interval is 100 ms. The sum is now 300 ms. It is not "in range". The next pp interval is 400 ms. Therefore the sum is now 700ms. It is "in range" and therefore 700ms is the corrected value. The three pp intervals (200ms, 100ms, and 400ms) will be combined into one value of 700ms. The device then returns to error detection mode.
As another example, if the range is 700ms - 1,000 ms, and the erroneous pp interval is 1,300 ms. There are no integers which one can divide 1,300 ms by that will result in a value "in range". Therefore, the next pp interval (300ms) is summed together to produce 1,600 ms. At this time, there is an integer which can be used in a division to produce a value "in range". The integer 2 results in a value that is "in range" (1600 / 2 =
800 ms). Therefore, the two erroneous values (1,300 ms and 300 ms) will be replaced with two (the integer number) values of 800 ms (the result of the division).
In exemplary embodiments, devices according to the present invention will be able to generate corrected values within one or two additional pp intervals. However, it is possible that a device may enter error correction mode indefinitely. Therefore, the present invention can include a safety mechanism to resolve this situation if it should occur.
For example, if the device remains in error correction mode for too long, then the device recalculates the range by applying a statistical method to all original data points encountered. That is, every unprocessed pp interval received from the PPG sensor is used. The range is then computed with a statistical based range calculation, for example, a standard deviation formula. In exemplary embodiments, the median pp interval is determined from all unprocessed pp intervals encountered (whether authentic or erroneous). The range is defined as 15 beats per minute below the median up to 15 beats per minute above the median. The pp intervals in the error queue are reprocessed according to the new range. Note that the range could also be computed with a subset of the unprocessed data points (e.g., the last 50 data points). The present invention also can include any method of recalculating the range to resolve an extended error condition.
As stated previously, PPG sensors are sensitive to movement and finger pressure.
They are also sensitive to bright light and cold fingers. Therefore, there are a number of factors that can cause multiple errors. In certain embodiments of the present invention, whenever the signal to noise ratio over ten seconds drops below 25%, the device may cycle a display of error messages (such as that shown in Fig 18) until the device exits from error correction mode. Thus, the user will be provided information on changes can be made to assist the device in gathering accurate pulse information.
The present invention also provides alternative methods for detecting and correcting errors in a heart rate interval data set. For example, there are a number of implementations that would permit the range and/or IBI thresholds to dynamically change as new heart rate interval values were detected. Such implementations may provide a marginal increase in accuracy in certain circumstances.
For example, the range may be continually assessed using a rolling window. The range may be initialized after receiving the first 10 seconds of pp intervals such that each consecutive IBI is less than 200ms. After this point, the range could be continually reassessed using a rolling window of the last 10 seconds of reliable data. The last 10 seconds of reliable data may or may not be consecutive. For example, the top of the range (r top) could be the highest p-p in the last 10 seconds of reliable data and the bottom of the range (r bottom) could be the lowest p-p in the last 10 seconds of reliable data.
Another alternative is to dampen the rate in which the range can dynamically expand and contract. For example, each time a new pp value is detected, the range could be updated in three steps. First the data set top (ds top) and the data set bottom (ds bottom) are identified from the last 10 seconds of reliable data. Second, the ds top and ds bottom are adjusted in a manner such that they do not change significantly from the previous ds top (p ds top) and the previous ds bottom (p ds bottom). For example, if the p ds top is greater than ds top, then ds top could be reset to p ds top - ((p ds top - ds top)/25+1). If p ds top less than ds top then ds top could be reset to p ds top + ((ds top -p ds top)/4 +
1). If p ds bottom is greater than ds bottom then ds bottom could be reset to p ds bottom -((p ds bottom - ds-bottom)/2 + 1). If p ds bottom is less than ds-bottom then ds bottom can be reset to ((ds-bottom - p ds-bottom)/25+1 ). Thus, r top would be equal to the adjusted ds top and r bottom would be equal to the adjusted ds bottom. A p-p would be considered "in range" if it is between r bottom and r top.
The above-described methodology can accomplish three objectives. First, it allows the range to dynamically increase and decrease. Secondly, the range can expand faster than it contracts. Third, the bottom of the range can expand faster than the top of the range. There are a number of ways to implement these methods and any implementation that accomplishes any of these three objectives is intended to be within the scope of the present invention.
Yet another alternative includes converting the computed pp range to a range of pulse rate values (prv) and comparing each newly detected prv (60,000/pp) to the pulse rate range.
"In range" could be determined by whether or not the new prv was less than the maximum prv (max-prv) and greater than the minimum prv (min-prv). Or, "in range" could refer to whether or not the new prv was sufficiently close to the range of prv values.
For example, the range top and range bottom could be expanded by a determined number of beats (i.e.
max prv = max-prv + 9 and min-prv = min-prv - 9). Thus, any new prv that is within 9 bpm of the data set range could be considered 'in range'.

As with pp ranges, prv range calculations can also be dynamic. That is, as new prv's arrive, the range could be recalculated if the new prv is considered to be reliable (e.g., IBI is not too large).
Another method for increasing error detection capabilities is to use two threshold values for determining how close a new IBI is from the previous IBI. For example, if the new IBI is less than the low threshold, it can be considered a "small jump".
If the new IBI is between the two thresholds, it can be considered a "significant jump". And if the new IBI is higher then the second threshold, it can be considered a "large jump". 'Thus, as new values come in, they could be assessed as to whether the new value is "in range" or "out of range", and whether the new IBI is a small jump, significant jump, or large jump.
Decisions on whether to display the value, use the value for updating the range, and/or whether to correct the value may be based upon such assessments.
Any heart rate related interval may be used for determining the significance of IBI
levels. For example, the inter-beat interval difference of two prvs (the prv IBI) could be used when assessing the proximity of the new pulse value to the previous pulse values. Thus, IBI's can be computed and assessed for pp intervals, prv values, rr intervals, hr values and the like.
Still another alternative includes using the direction of the IBI change to determine whether the jump is small, significant, or large. When a person is physically still, pulse rates can rise or fall at different rates. Thus, different thresholds could be used depending on the direction of the change. For example, a prv IBI that's greater than the previous prv IBI could be considered to be a small jump up if it is less than 8 bpm, a significant jump up if it is between 8 - 15 bpm, and a large jump up if it is greater than 15 bpm. And a prv IBI that's smaller than the previous prv IBI could be considered a small jump if it is less than 8 bpm, a significant jump if it is between 8 - 12 bpm, and a large jump if it is greater than 12 bpm.

Yet another exemplary embodiment includes basing the prv IBI thresholds on the location of the previous prv in the range. If the previous prv is already toward the top of the range, the threshold could be set smaller, since in theory, one would not want the next prv to jump too far outside the range. Likewise, if the previous prv is already toward the bottom of the range, the prv thresholds for jumping down could be decreased. Thus, examples of prv IBI thresholds based on the location of the previous prv in the range could include: ((r top -prev-prv)(1/3))+10 for a small jump up, ((r top - prev-pr)(2/3))+15 for a large jump up, ((prev-prv - r bottom)( I /2))+10 for a small jump down, and ((prev-prv - r bottom) x (2/3))+15 for a large jump down.
Yet another exemplary embodiment is to add a third test such as direction when determining if a new heart rate interval point needs to be corrected. For example, if the point fails the IBI and the range tests, but is closer to the range then the previous heart rate interval point, then it could still be considered acceptable.
In certain circumstances and implementations, a marginal improvement may be obtainable by combining the dynamic range method, the double IBI threshold method with different thresholds based upon direction, and the heart rate interval direction method. An example of such a combination is as follows. As each new prv is calculated (60,000/pp), it can first be assessed whether or not it is 'immediately displayable'. If the prv is a small jump up or small jump down (using appropriate thresholds) it is 'immediately displayable' and therefore is immediately displayed. If it is a significant jump but is 'in range' then it is 'immediately displayable' and therefore is immediately displayed. Otherwise, it could be re-evaluated by direction to see if it is displayable. If the current prv is closer to the range than the previous prv, then it is still displayed. Otherwise, it is not displayed and must be corrected.

Combinations of the above-described methods also may be used to determine when a value was 'reliable' or not. That is, these methods may be used to determine whether a new prv should be used in recalculating the dynamic range. For example, if the new prv is a small jump, it could be considered 'reliable'. If the new prv is a significant jump, but is 'in range' then it could be considered 'reliable'. And if the new prv is a significant jump and 'out of range' but is closer to the range than the previous prv, then it can be considered 'reliable'.
In deciding which methods to employ to detect and correct errors in a data set, one should consider the hardware stability, use environment, and other factors to determine if the degree of potential statistical advantage of complex combinatorial methods offers a greater practical utility over the basic IBI/range methodology. In most situations the basic IBI/range strategy is quite sufficient. If, however, significant movement, sunlight, pressure and similar factors are expected to be present, the additional statistical methodology described above may be implemented to provide even greater accuracy in detection and correction of errors in a data set.
Resolution of Scaling Problems and Identification of Rhythmic Breathing Methods and devices according to exemplary embodiments of present invention not only use wave information to assess stress, determine an accurate average heart rate, and provide feedback on the wave frequency, but also use the wave information to innovatively scale the area of the display where the waves are shown.
The amplitude of RSA waves can vary significantly from person to person. As described earlier, RSA amplitude depends on the individual's age, sex, fitness level, breathing pattern, and more. While large display screens can accommodate large waves or small waves, small display screens on portable devices require sophisticated scaling. Thus, if the scale on a small display is too small, then large waves will not fit on the display. If the scale is too large, then the shape and size of small waves will become indiscernible. And if the scale is too dynamic and adjusts too frequently, then large waves and small waves will appear to be the same size, and the user will not be able to discern whether or when his breathing pattern has changed.
Devices according to the exemplary embodiments of the present invention can solve the scaling issue by adjusting the display scaling differently during two stages. The first stage lasts from the time the device is powered on until the user begins to breathe rhythmically. The second stage lasts from the time the device detects rhythmic breathing until the device is turned off. During stage l, a very basic scaling technique can be implemented. During stage 2, an innovative approach can be employed so the user can accurately assess when his breathing has become more shallow (less deep).
For example, when the device is first turned on, the scaling is preferably zoomed in to a small, preset value. Then, the device zooms out whenever a pulse rate point is encountered that is greater than highest value or lesser than the lowest value that can be plotted using the current zoom level. The scale is zoomed out such that the new pulse point is plotted at the edge of the device display area. To give the user an idea of scale, the device only zooms out, not in, at the beginning. The display also zooms back in after large waves have exited the screen, so that the full height of the display is used from top to bottom. The display continually zooms in and out such that the data points being shown consume the full range of the display at all times until the user begins rhythmic breathing.
Once the user begins to breathe rhythmically, the device seeks to encourage him to breathe deeply. If the device continued to automatically zoom in when small waves appear, then the small waves produced by shallow breathing will appear the same size as the large waves produced by deep breathing. This will not allow a user to visually discern his depth of breathing from the size of the waves.

Devices according to exemplary embodiments of the present invention use the wave information to detect rhythmic breathing. Rhythmic breaths produce waves with uniform wavelengths, frequencies, amplitudes, peak to peak times, and peak placement times (Fig.
35). By measuring the variance of one or more of these wave feature parameters, rhythmic breathing can be identified. Exemplary embodiments calculate the variation of the wavelengths and amplitudes of the last three waves. When both of these variations are low, then rhythmic breathing is considered to have begun.
One method of determining variance, and thus establishing when a variance is small, can be based on the percent relative deviation. This method is useful when comparing the variation of two or more values (e.g., peak-to-peak times, wavelengths, frequencies, etc.).
This may be done as described below. First the mean (average) of the values can be determined. Then the sum of the difference (sum dif) of each value from the average can be computed. The sum can be divided by the average x number of values. For example, consider four wavelengths: 10, 8, 10, 8 seconds. The average is 9. The sum of the differences from the mean is 4 (10 is 1 away, plus 8 is 1 away, plus 10 is 1 away, plus 8 is 1 away). Thus 4 is divided by the mean x number of values (4 /(9 x 4)). Thus the percent relative mean deviation is 11.1%. Consider four amplitudes: 30, 28, 30, 28 bpm. Although the deviation is also 4 as in the previous example, the percent relative mean deviation is only 3.4%. Thus, percent relative mean deviation automatically scales itself to the range of the values being analyzed.
The variance of any of the wave features can be analyzed alone or in combination using numerous methods. The preferred embodiment employees percent relative mean deviation. The greater the resulting percentage, the greater the variance. A
variance threshold could be set to determine if rhythmic breathing has commenced. For example, if three or more waves have a variation in a wave feature less than 20%, one may conclude that rhythmic breathing has commenced. In a preferred embodiment, rhythmic breathing is considered to have commenced when the variation of the wavelength and amplitude of the last three waves is less than 10% each.
Once rhythmic breathing has begun, the can keep track of the largest amplitude (maximum amplitude) formed by the resulting rhythmic waves. The device continues to determine if the user is still breathing rhythmically with, for example, each and every wave.
As long as the user continues to breathe rhythmically, the device will continue to look for the largest amplitude (maximum amplitude). If a newly formed rhythmic wave has a higher amplitude than the current maximum amplitude, then the maximum amplitude can be readjusted to be equal to the new amplitude. In general, the display does not zoom in more than the maximum amplitude. That is, the display scale can be set such that a wave with an amplitude equal to the max amplitude would fully consume the screen from top to bottom.
The zoom level can be set to not exceed this set point. As a result, the device can zoom out, but it may not zoom in beyond the set point determined by the maximum amplitude. In this way, users will notice when they are breathing shallowly, because they will see the relatively smaller waves (relative to the maximum amplitude) on the screen.
Sometimes an erroneous wave (a wave with corrected errors that is incorrectly reconstructed) can have the largest amplitude. This large amplitude may be erroneously high.
Also, a person's largest possible amplitude can degrade with time until their lungs become used to rhythmic breathing. That is, as their lungs become tired, they will not be able to reproduce waves with amplitudes equal to the maximum amplitude. Since the device should not frustrate the user, but rather encourage him to produce the largest waves that he comfortably can, the device can decrease the maximum amplitude value over time if a successive series of waves do not come sufficiently close to the maximum amplitude. In preferred embodiments, if three consecutive rhythmic waves have amplitudes less than 80%

of the max amplitude, the maximum amplitude may be readjusted using the following formula: (largest amplitude of the last three waves) x (100 / 85). Another alternative is to continually decrease the maximum amplitude until the waves are sufficiently close to occupying the display from top to bottom. For example, the maximum amplitude could be decremented by 5% every time a newly formed rhythmic wave has an amplitude less than 80% of the current max amplitude. Another way to use amplitudes would be to take the highest average amplitude. For example, the average amplitude of the last three waves could be calculated every time a new wave is encountered. The highest average amplitude can be used as the minimum set point.
The use of high amplitudes which occur in rhythmic breathing to establish set points is a novel and useful component of the disclosed invention. Any scaling based upon amplitude, range, variance, or deviation is intended to be within the scope of this invention.
For example, the standard deviation of the data set, or subset of the data, could be determined. The maximum zoom level could be set such that values with a certain probability relative to the deviation consume the screen. For example, all values that have an 80% probability of being within the standard deviation would fill the screen from top to bottom.
Exemplary System and Software Process An exemplary embodiment of the present invention can be implemented, for example, as a process stored in a memory of a data processing device, such as, for example, a computer.
Such a process, can, for example, be in the form of software, and can, for example, be executed by a data processor or CPU and the results displayed on a display, such as, for example, a CRT, plasma or other computer display as is known in the art. Thus, for example, such software can be implemented on a system comprising a CPU, a memory, and a display, all connected by one or more busses or data pathways. Fig. 55 depicts such an exemplary system.
With reference thereto, there is provided an I/O or input/output interface 5501, a CPU 5505 and a memory 5510. The three components of the exemplary system are communicably connected via a system bus 5520. As noted, system bus 5520 is a logical component, and in any given embodiment, can comprise a plurality of interconnections between system elements. Given such an exemplary system, a software process can be loaded in memory 5510 and executed in CPU 5505. Moreover a user can provide input to the process via the I/O 5501, and output to user by way of visual, auditory, tactile, or other means can be provided to a user also using the I/O. Such I/O can comprise a physical interface device, comprising one or more sensors, or can, for example, comprise one or more of a microphone and one or more speakers, a keyboard, mouse and visual display, and a tactile input and output mechanism .
Additionally, such a software process can, for example, be expressed using any appropriate computer language or combination of languages using known techniques, and can be, for example, implemented as an embedded system or a conventionally stored program of instructions using known techniques. Such a software process can be implemented, for example, on a device which can be used to evaluate stress in humans, as described above.
Such an exemplary software process can have, for example, a top level process that interacts with a user by displaying messages to a user and by, for example, continually looking for and responding to various user actions, such as, for example, a user pressing a breathing guidance button or a pulse emanating from a user's finger. Such an exemplary software process is depicted in Figs. 36-54, as next described. It is noted that Figs. 8(a)-(b), described above, integrate with this exemplary software process, and thus the "process waves"
subroutine, described below in connection with Fig. 49, calls the subroutine "get waves"
depicted in Figs 8(a)-(b).
Figs. 36-37 depict an exemplary top level process, which can control what is displayed to a user and can, for example, respond to user actions. This top level process essentially initializes variables and then waits for interrupts to which it responds. With reference to Fig.
36, at 3601 variables can be initialized. This initialization can include, for example, setting the device mode to "Spontaneous" and setting the values for the following variables to zero:
number of raw timesteps, number of timesteps, number of pp intervals, number of interbeat intervals, error sum, number of waves, number of pp intervals and number of pp interval timesteps, as well as setting the variable state to RAW. This initialization can, for example, be implemented according to the following pseudocode: n rt = 0; n is = 0; n-pp = 0; n-ibi =
0; state = RAW; err sum = 0; n waves = 0; n val4 =~0; n-ppts = 0.
Continuing with reference to Fig. 36, at 3602, for example, an "Insert Finger"
message can be displayed to a user. At 3603, the process waits for an interrupt, taking no further action until one occurs. At 3604, if a finger is inserted by a user then at 3610, for example, the device begins calibration, the display message is updated and the interrupt cleared, returning to 3602.
Process flow for this exemplary top level process continues as depicted in Fig. 37. With reference to Fig. 37, at 3710, if a user presses the breathe button, as described above, this can trigger a Breathe Button Pressed Interrupt. Process flow then moves to 3720, for example, where the device mode is set to "Guided", the variable Start set to be the current time and the interrupt cleared. Process flow can then move to 3721, where a clock interrupt can be, for example, set to 100 milliseconds. Process flow can then move to 3730, where the Guided Mode display can be presented to the user. Process flow then returns through breakpoint 2 in Fig. 37 back to 3603 of Fig. 36, where the top level process again waits for another interrupt to occur. This brings process flow back to Fig. 37 through breakpoint I
where, at 3711, for example, if a clock interrupt occurs, process flow moves to 3703, and tests whether less than two minutes have elapsed from the time the user pressed the Breathe Button at 3710 and entered Guided Mode. If it is still less than two minutes, process flow can move through 3731 to 3730 where the Guided Mode display can be, for example, updated. 1f at 3703, for example, it has been longer than two minutes since the user pressed the Breathe Button, then process flow can move to 3702, the Mode variable is reset to "Spontaneous", and process flow moves to 3701 where, for example, the Spontaneous Mode display is restored.
Finally, with respect to Fig. 37, at 3712, if a pulse is detected, a Pulse Detected Interrupt occurs, and process flow moves, for example, to 3713, where the Process Pulse subroutine is called. This ends the exemplary top-level process depicted in Figs. 36 and 37.
Figs. 38-42 depict process flow of an exemplary main routine according to an exemplary embodiment of the present invention, entitled Process Pulse. Process Pulse calls the subroutines error correction (Figs. 43-45), error detection (Figs. 46-47), initialize range (Fig. 48) and process waves (Figs. 49-50). In turn, process waves calls subroutines get waves (Figs. 8(a)-(b)) and determine stress (Figs. 51-53). Thus all of the subroutines are called, directly or indirectly, by Process Pulse.
With reference to Fig. 38, at 3802, the raw timestep rt[n rt], which is rt[0], given the initialization at 3601 of Fig. 36, is set to the current time in milliseconds, and n rt, or the number of raw timesteps, is preincremented. Then, for example, at 3803, 3804 and 3805, the variable state can be tested for being RAW, DETECTION or CORRECTION to determine whether the data is assumed to be error-free, suspect or erroneous, and accordingly along which path process flow will continue. If state = CORRECTION the data path beginning at 3805 will be taken, calling an error correction subroutine at 3805. If state =
DETECTION, the data path beginning at 3804 will-be taken, ultimately calling an error detection subroutine at 3910 of Fig. 39. These two data pathways ultimately arrive at 4011 of Fig.
40. If state =
RAW, process flow can continue directly to 3901 of Fig. 39 where timing variables are initialized, including preincrementing n ts, a variable that tracks the number of timesteps, and through 3902 where n is is verified to be greater than one. (f that is the case, at 3903, for example, n val, the number of pp intervals to be assigned, can, for example, be set equal to I, and process flow can continue, through breakpoint 9, to 4010 of Fig. 40, and through to 4011.
When process flow reaches 4011 there are one or more pp values needing to be assigned.
Thus, at 4011, each pp value is assigned a value and if there are more than one pp values (i.e., n val >1) then the actual time steps can be generated, and the instantaneous pulse rate is displayed, which is the frequency of the current pp interval determined by (60000/pp[n_pp-1]). From 4011 process flow continues to 4110, where if there are more than one pp values, calculation of interbeat intervals (IBI's) is possible. This at 4110 the process tests for this condition, and if yes, IBI values can, for example, be calculated at 4111. If not, process flow can loop back to 4010. At 411 l, once IBI values are calculated, process flow moves to 4201 to test how many pp values there are. If there are more than 8, i.e., at least 9, then there is sufficient data to identify a level 4 valley. Once there is are at least two level 4 valley points, i.e., num val4 > 1 at 4212 the exemplary process can look for RSA waves, as described above. Thus, a yes at 4212 can, for example, cause the process flow to call a process waves subroutine at 4213.
Figs. 43-45 depict an exemplary process flow for an error correction subroutine. As described above in connection with the exemplary Process Pulse routine, at 3805 of Fig. 38, an error correction subroutine is called. With reference to Fig. 43, process flow begins at 4301, where the subroutine begins. At 4302, for example a variable err sum, which accumulates current pp interval times, has the most recent pp interval added to it.

Additionally, the variable n val is set to 0. Process flow continues at 4303, where the new value for err sum is tested as to whether it is in range. If it is in range, process flow can move, for example, to 4310, where the variable n val is set to l, representing a correct pp interval being identified, and the value of that pp interval is set equal to the number of milliseconds in err sum, and process flow returns at 4320 to Process Pulse. On the other hand, if at 4303 the tentative pp interval time is not within range, process flow can move to 4304, where, for example, the subroutine tests whether the current pp interval time is below the range. If yes, process flow returns to 4302 and an additional pp interval time is added to the variable err sum. If no, then the current sum is considered as too high and a suitable integer must be found with which to divide it to create two or more "in range"
pp intervals.
Process flow then continues from 4304 through breakpoint 20 to 4401 of Fig.
44.
There, test integer = 2 is set as a test divisor and process flow can move, for example, to 4402 where a temporary variable tmp val is set up to hold the quotient of err sum/test integer, representing a possible actual corrected pp interval.
Process flow can then move to 4403, where, for example, tmp val is tested for being above the range. If yes, then at 4410; for example, the test integer variable is incremented and the proposed division occurs one more time at 4402. On the other hand, if at 4403 tmp val is not above the range, than at 4404, for example, tmp val can again be tested for being within the range, and if yes, process flow can move (through breakpoint 21) to 4501 of Fig. 45.
At 4501 of Fig. 45, a count variable can be set to l, and at 4502, for example, the subroutine can query whether count is less than the current value of test- integer. If no, then process flow can move, for example, to 4510, and the variable n val can be set equal to test integer and at 4520, for example, return to Process Pulse, at breakpoint 6 of Fig. 38.
On the other hand, if count is less than test integer at 4502, then process flow can, for example, loop through 4503, 4504 and 4502, incrementing the value of count each loop (at 4504) until count equals test integer, at which time process flow can return to Process Pulse.
Next described is an exemplary error detection subroutine with reference to Figs. 46-47.
With reference to Fig. 46, process flow begins at 4601 and continues to 4602, where a current pp interval is loaded into temporary (in the sense of tentatively correct) pp interval tmp-pp .
At 4603, the tmp-pp is tested for being within range. If yes, then n val is set to 1 and val[0]
is set equal to tmp-pp at 4610 and at 4620 process flow returns to the calling program, Process Pulse, in particular to 3911 in Fig. 39. However, if at 4603 tmp-pp is found to be out of range then, at 4604, temporary interbeat interval variable tmp-ibi is generated to use in detecting any errors as described above. Process flow can then continue (through breakpoint 22) to 4701 of Fig. 47, where tmp ibi is tested for being greater than half the lower end of.the range, which is a test for being too large, as described above. If yes, there is assumed to be an error, and flow continues to 4702, where the variable err sum is set equal to tmp-pp (err sum is an input to the error correction subroutine described above), "state" is set to be CORRECTION, and process flow can move, for example, to 4703 where n val is set to 0 and process flow returns to Process Pulse, which can then, based on n val = 0 and state =
CORRECTION, return at 3911 of Fig. 39 to 3820 of Fig. 38, and ultimately flow to an enor-correction subroutine at 3805.
If at 4701 tmp ibi is not greater than half of the lower end of the range, in which case it is not considered to be large and thus no error present in the pp interval data, process flow can continue to 4710, and, for example, test whether the tmp-pp is greater than the top of the range. Because tmp ibi was not found to be large at 4701, and thus no error is assumed present, if at 4710 the tmp_pp interval is stil I larger than the existing top of the range, the range needs to be recalculated using the new pp interval as max_pp, which holds the value for the maximum possible pp interval which is not the result of an error in the data. At 4711, for example, max-pp can be set equal to tmp~p and, using this new value, at 4712, for example, the upper and lower ends of the range are recalculated. Flow can then continue, for example, to 4713 where the n val is set equal to 1 and val[0] is set equal to the current pp interval, tmp-pp. At 4714, for example, process flow can return to the calling routine Process Pulse. If at 4710 the current pp interval is not greater than the existing upper end of the range then, for example, at 4720 the minimum possible pp interval is set equal to the current pp interval. Then process flow continues as described above through 4712, 4713 and 4714, where process flow returns to the calling program.
W ith reference to Fig. 48, process flow for the subroutine initialize range is next described. This subroutine can be used in exemplary embodiments of the present invention to calculate the range for pp intervals within which the data is assumed to be error free, for use in the error detection and correction routines. Beginning at 4801 at the subroutine call, process flow moves, for example, to 4802, where the variables min-pp and max-pp are set using the following pseudocode: min-pp = lowest pp in data set; max-pp =
highest pp in data set. Then, for example, at 4803, the upper and lower ends of the range of data points used for error detection and correction, as described above. This can, for example, be implemented using the following pseudocode: range high = max-pp + ((max-pp - min-pp)*0.25;
range low = min~p - ((max-pp - min-pp)*0.25). Using these exemplary values, the range is now set, and at 4804 process flow returns to the calling routine, i.e., Process Pulse. In particular, process flow returns to 4102 in Fig. 41.
Figs. 49-50 depict an exemplary process flow for a wave processing subroutine.
In an exemplary embodiment of the present invention, such a subroutine can be called, for example, by a pulse acquisition processing routine such as Process Pulse, as described above.
After the subroutine is called at 4901, for example, process flow can continue at 4902, where the get waves subroutine described above can be called to input the waves identified from the pulse data. Process flow continues, for example, to 4903, where, given the acquired waves, a score indicative of a user's stress level reflected in the identified waves can be assigned using an exemplary determine stress subroutine. Flow can then continue, for example, to 4904 where the waves are sorted and the instantaneous frequency calculated based on the current pp interval using the expression frequency = 60000 /
(ppts[v2[n waves-1]J - ppts[vl [n-waves-1]]), where ppts[v] is the pulse point time stamp at data point v .
From there, for example, process flow can continue to 5001 on Fig. 50, where a score between 0-3 can be assigned to a user based upon the frequency of the current wave, where a higher score indicates a lower stress level. At 5002, for example, the subroutine can, for example, display to the user each of his or her (i) stress level (obtained from the call to determine stress at 4903); (ii) frequency (from 4904); and (iii) score (from 5001), at which point, for example, at 5003, process flow can return to the calling routine, Process Pulse.
Figs. 51-53 depict an exemplary subroutine for determining a stress score.
What is being measured is how unrelaxed a given user is, by operating on the wavelengths of his or her RSA waves. With reference to Fig. 51, at 5104 the determine stress subroutine calls assigned wavelengths, which assigns a wavelength between w1 to and w1 high (which are set at 5102) to each wave. Using these wavelengths and how many waves there are (i.e., the value of n waves), Figs. 51-52 depicts process flow for each value of n waves between 1 and 4. A scorel is determined at each of 5110, 5201, 5202 and 5203, which is a weighted sum of the differences between each wave's wavelength and w lo, which measures how far off the baseline that particular wave is. Thus, a perfect relaxation score would have a w[n} = w to for all n, and each scorel would equal zero. In alternate exemplary embodiments of the present invention scorel can be calculated without weighting the sums of differences, and this is the method as described above. Scorel is what was described as the "wavelength"

score. As can be seen at each of 5110, 5201, 5202 and 5203, a "variance"
score, score2 is also computed. Scorel and score2 can be combined at 5302 using a 70/30 relative contribution factor to obtain score3. Other relative weightings can be used in alternate exemplary embodiments according to the present invention as may be found useful. Score3 can be used to calculate stress level using, for example, the equation stress level = (score3 -21)* (100/(100-21 )). Stress level is returned to process waves at 4903.
With reference to Fig. 54, an exemplary subroutine for assigning wavelengths to acquired waves is depicted. This subroutine can be used, for example, in the exemplary determine stress routine depicted in Figs. 51-53, as described above, which takes wavelengths as inputs. 1n an exemplary embodiment of the present invention, process flow can begin at 5401 with a call to the subroutine. At 5402 a counter variable n is set equal to zero, and at 5403, for example, a current wavelength w1 is calculated by subtracting the timestamp of the current v2 from that of the current v1, using the expression w1 = is[v2[n]] -is[vl [n]]. At 5404 and 5405, for example, the value of w1 is compared with that of w1 to and w1 high, which can be set in the calling subroutine as seen at 5102 of Fig. 51 (where, for example, they are set as 3 and 10, respectively). If w1 is less than w1 to or higher than w1 high, a wl[n] is truncated at either w1 to or w1 high, as the case may be, and flow continues at 5407 where the value of n is preincremented. If, however, w1 has a value between w1 low and w1 high, then, for example, at 5406, a wl[n] is set to w1, and process flow continues to 5407. At 5408 the value of n is compared with that of n waves, to insure that each acquired wave has been assigned a wavelength. If they are equal, at 5410, for example, process flow ends for this subroutine, and returns to 5105 n Fig. 51.
If they are not equal, then flow loops through 5403 for each acquired wave until all acquired waves have been assigned wavelengths.

Claims (39)

1. ~A method of identifying at least one RSA wave in a subject comprising:
recording heart rate related intervals over time; and analyzing heart rate related intervals sufficient to delineate at least one individual~~
RSA wave, wherein said delineation includes identifying at least one transition point in the at least one individual RSA wave.
2. ~The method of claim 1, wherein the heart rate related interval is a pp interval.
3. ~The method of claim 1, wherein the heart rate related interval is a rr interval.
4. ~The method of claim 1, wherein the at least one transition point is used to determine wave depth and the wave depth is used to determine at least one valley point or peak point in the at least one individual RSA wave.
5. ~A method of reducing stress in a human subject comprising:
providing a subject with near real-time RSA wave information, wherein said information is derived from recording more than one heart rate related intervals of the subject; and analyzing the more than one heart rate related interval of the subject sufficient to delineate at least one individual RSA wave, wherein said delineation includes~
identifying at least one transition point in the at least one individual RSA
wave.
6. ~The method of claim 5, wherein the heart rate related interval is a pp interval.
7. ~The method of claim 5, wherein the heart rate related interval is a r-r interval.
8. ~The method of claim 5, wherein said delineation comprises the identification of at least one top point and at least two bottom points.
9. ~A method for identifying rhythmic breathing comprising:
comparing at least two consecutive RSA waves; and determining when there is a small variation in at least one wave feature of the at least two consecutive RSA waves.
10. ~The method of claim 9, wherein the wave feature is selected from the group consisting of wavelength, frequency, amplitude, peak to peak time, and peak~
placement time, alone or any combination.
11. ~The method of claim 10, wherein the wave feature is wavelength and the small variation is 20% or less relative mean deviation.
12. ~The method of claim 10, wherein the wave feature is frequency and the small variation is 20% or less relative mean deviation.
13. ~The method of claim 10, wherein the wave feature is amplitude and the small variation is 20% or less relative mean deviation.
14. ~The method of claim 10, wherein the wave-feature is peak to peak time and the small is 20% or less relative mean deviation.
15. ~The method of claim 10, wherein the wave feature is peak placement time and the small is 20% or less relative mean deviation.
16. ~A handheld, portable biofeedback device for reducing stress in a human subject comprising:
a housing:
a PPG sensor disposed in the housing, wherein the PPG sensor generates data from the human subject;
a control system coupled to the PPG sensor; and a display screen, wherein the control system is configured to process data from the human subject for output to the display screen, the output data providing the human subject with information associated with the human subject's stress level; and wherein the housing, PPG sensor, control system and display screen form an integrated structure.
17. ~The device of claim 16, wherein the housing includes a power source.
18. ~The device of claim 16, wherein power is provided by an A/C source.
19. ~The device of claim 16, wherein during respiration of a human subject said device is configured to record multiple heart rate related intervals of the subject;
and analyze heart rate related intervals sufficient to delineate at least one individual RSA
wave.
20. ~The device of claim 19, wherein the heart rate related interval is a pp interval.
21. ~The device of claim 19, wherein the heart rate related interval is a r-r interval.
22. ~The device of claim 19, wherein said delineation includes identifying a set of transition points in each individual RSA wave.
23. ~The device of claim 22, wherein the set of transition points includes at least one top point and at least two bottom points.
24. ~The device of claim 16, further comprising a breathing metronome capable of being activated by a subject, wherein the breathing metronome is programmed to deactivate after a predetermined period of time.
25. ~The device of claim 19, wherein the device further comprises a breathing metronome capable of being activated by a subject, wherein the breathing metronome is programmed to deactivate after a predetermined period of time.
26. ~The device of claim 16, wherein the device is configured to extract information related to respiration of a subject.
27. ~The device of claim 26, wherein the information related to respiration includes rate, rhythm and volume.
28. ~A method of detecting erroneous data relating to RSA wave delineation comprising:
identifying at least 2 consecutive heart rate related intervals. having an IBI
time less than a predetermined threshold or a threshold derived from a heart rate related interval set;
calculating a range for the IBI times of the at least 2 consecutive heart rate related intervals; and comparing each subsequent heart rate related interval with the calculated range to determine if it is within said range.
29. ~The method of claim 28, wherein the heart rate related interval is a pp interval.
30. ~The method of claim 28, wherein the heart rate related interval is a rr interval.
31. ~The method of claim 28, wherein the IBI time is less than 500ms.
32. ~A method of correcting erroneous data relating to RSA wave identification comprising:
identifying a heart rate related interval which is both not within a predetermined range and has an IBI time greater than a threshold;
calculating a corrected heart rate related interval wherein if the first heart rate related interval is less than the predetermined range, adding subsequent heart rate related intervals to the first heart rate related interval until the sum of said intervals is within or above the predetermined range;
if the first heart rate related interval or sum of said intervals is greater than the predetermined range and not divisible by an integer, adding subsequent heart rate related intervals to the first heart rate related intervals until the sum of said intervals is divisible by an integer such that the quotient is within the predetermined range; and creating a corrected RSA wave based on the corrected heart rate related interval.
33. The method of claim 32, wherein the heart rate related interval is a pp interval.
34. The method of claim 32, wherein the heart rate related interval is a rr interval.
35. A method of adjusting scaling on the display of a portable biofeedback device during rhythmic respiration of a subject comprising:
determining the highest amplitude of RSA waves over time; and maintaining the scaling to correspond to the largest wave formed during respiration.
36. A computer program product comprising a computer usable medium having computer readable program code means embodied therein, the computer readable program code means in said computer program product comprising means for causing a computer to:
record heart rate related intervals over time; and analyze heart rate related intervals sufficient to delineate at least one individual RSA
wave, wherein said delineation includes identifying a set of transition points in each individual RSA wave.
37. A program storage device readable by a machine, tangibly embodying a program of instructions executable by the machine to perform a method for identifying at least one RSA
wave in a subject comprising:
recording heart rate related intervals over time; and analyzing heart rate related intervals sufficient to delineate at least one individual RSA wave, wherein said delineation includes identifying a set of transition points in each individual RSA wave.
38. A computer program product comprising a computer usable medium having computer readable program code means embodied therein, the computer readable program code means in said computer program product comprising means for causing a computer to:
compare at least two consecutive RSA waves; and determine when there is a small variation in at least one wave feature of the at least two consecutive RSA waves.
39. ~A program storage device readable by a machine, tangibly embodying a program of instructions executable by the machine to perform a method for identifying rhythmic breathing comprising:
comparing at least two consecutive RSA waves; and determining when there is a small variation in at least one wave feature of the at least two consecutive RSA waves.
CA2560294A 2004-03-18 2005-03-18 Methods and devices for relieving stress Active CA2560294C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55421104P 2004-03-18 2004-03-18
US60/554,211 2004-03-18
PCT/US2005/009139 WO2005089856A1 (en) 2004-03-18 2005-03-18 Methods and devices for relieving stress

Publications (2)

Publication Number Publication Date
CA2560294A1 true CA2560294A1 (en) 2005-09-29
CA2560294C CA2560294C (en) 2014-05-27

Family

ID=34993466

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2560294A Active CA2560294C (en) 2004-03-18 2005-03-18 Methods and devices for relieving stress

Country Status (11)

Country Link
US (2) US7691049B2 (en)
EP (1) EP1729845B1 (en)
JP (1) JP2007529283A (en)
KR (1) KR101224346B1 (en)
CN (1) CN1968727B (en)
AU (1) AU2005222712A1 (en)
BR (1) BRPI0508896A (en)
CA (1) CA2560294C (en)
MX (1) MXPA06010498A (en)
WO (1) WO2005089856A1 (en)
ZA (1) ZA200607757B (en)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713212B2 (en) * 2003-11-03 2010-05-11 Coherence Llc Method and system for consciously synchronizing the breathing cycle with the natural heart rate cycle
US20060047202A1 (en) * 2004-09-02 2006-03-02 Elliott Stephen B Method and system of breathing therapy for reducing sympathetic predominance with consequent positive modification of hypertension
WO2006050725A1 (en) * 2004-11-10 2006-05-18 Medicus Engineering Aps Method and apparatus for recording and presentation of physiological data
US7458937B2 (en) * 2005-01-11 2008-12-02 Coherence Llc Method and system for assessing breathing effectiveness via assessment of the dynamic arterial pressure wave using the oscillometric measurement technique
US7635337B2 (en) * 2005-03-24 2009-12-22 Ge Healthcare Finland Oy Determination of clinical stress of a subject in pulse oximetry
JP2008536648A (en) * 2005-04-20 2008-09-11 ヘリコール・インコーポレーテッド Method and apparatus for relieving stress
AU2006332837A1 (en) 2005-12-28 2007-07-12 Nirinjan Bikko Breathing biofeedback device
US9779751B2 (en) 2005-12-28 2017-10-03 Breath Research, Inc. Respiratory biofeedback devices, systems, and methods
US8095199B2 (en) * 2006-04-25 2012-01-10 Beijing Choice Electronic Technology Co., Ltd. Portable electrocardiograph with a neutral electrode
JP4965205B2 (en) * 2006-09-13 2012-07-04 テルモ株式会社 Heart rate fluctuation detection device
KR100855473B1 (en) * 2006-11-03 2008-09-01 학교법인 한림대학교 Apparatus for controlling respiration rate based on pulse beat data of heart
US20080269629A1 (en) * 2007-04-25 2008-10-30 Robert Howard Reiner Multimodal therapeutic and feedback system
US20080269652A1 (en) * 2007-04-25 2008-10-30 Robert Howard Reiner Multimodal therapeutic system
WO2008139380A2 (en) * 2007-05-14 2008-11-20 Koninklijke Philips Electronics N.V. System and method for guiding breathing exercises
US20090076345A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Adherent Device with Multiple Physiological Sensors
US8460189B2 (en) 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
US8790257B2 (en) 2007-09-14 2014-07-29 Corventis, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US9186089B2 (en) 2007-09-14 2015-11-17 Medtronic Monitoring, Inc. Injectable physiological monitoring system
WO2009036348A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Medical device automatic start-up upon contact to patient tissue
US20090076343A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Energy Management for Adherent Patient Monitor
US8591430B2 (en) 2007-09-14 2013-11-26 Corventis, Inc. Adherent device for respiratory monitoring
DE102008030956B4 (en) 2007-10-16 2010-01-07 Biosign Gmbh Device for measuring heart rate variability
WO2009104127A1 (en) * 2008-02-22 2009-08-27 Koninklijke Philips Electronics N.V. A system and kit for stress and relaxation management
EP2257216B1 (en) 2008-03-12 2021-04-28 Medtronic Monitoring, Inc. Heart failure decompensation prediction based on cardiac rhythm
EP2100556A1 (en) * 2008-03-14 2009-09-16 Koninklijke Philips Electronics N.V. Modifying a psychophysiological state of a subject
JP5878692B2 (en) 2008-03-14 2016-03-08 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Method and system for maintaining the state of an object
US8412317B2 (en) 2008-04-18 2013-04-02 Corventis, Inc. Method and apparatus to measure bioelectric impedance of patient tissue
KR100943180B1 (en) * 2008-05-07 2010-02-19 (주)더힘스 Method and apparatus for providing relaxation response by guiding respiration
RU2511278C2 (en) * 2008-05-09 2014-04-10 Конинклейке Филипс Электроникс Н.В. Patient's respiration noncontact control and optic sensor for photoplethysmographic measurement
WO2009147625A1 (en) * 2008-06-06 2009-12-10 Koninklijke Philips Electronics N.V. Method of obtaining a desired state in a subject
JP5519651B2 (en) * 2008-06-06 2014-06-11 コーニンクレッカ フィリップス エヌ ヴェ Method and system for maintaining state in a subject
WO2010005536A2 (en) * 2008-07-08 2010-01-14 The Johns Hopkins University Non-invasive methods and systems for assessing cardiac filing pressure
ES2336997B1 (en) * 2008-10-16 2011-06-13 Sabirmedical,S.L. SYSTEM AND APPARATUS FOR NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE.
EP2198911A1 (en) * 2008-12-19 2010-06-23 Koninklijke Philips Electronics N.V. System and method for modifying the degree of relaxation of a person
EP2277437A1 (en) 2009-07-22 2011-01-26 Koninklijke Philips Electronics N.V. Method and system for adaptive breath pacing
WO2011050283A2 (en) 2009-10-22 2011-04-28 Corventis, Inc. Remote detection and monitoring of functional chronotropic incompetence
US9451897B2 (en) 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
US8715179B2 (en) * 2010-02-18 2014-05-06 Bank Of America Corporation Call center quality management tool
US8715178B2 (en) * 2010-02-18 2014-05-06 Bank Of America Corporation Wearable badge with sensor
US9138186B2 (en) * 2010-02-18 2015-09-22 Bank Of America Corporation Systems for inducing change in a performance characteristic
US8965498B2 (en) 2010-04-05 2015-02-24 Corventis, Inc. Method and apparatus for personalized physiologic parameters
US9017256B2 (en) * 2010-09-22 2015-04-28 Milieu Institute, Llc System and method for physiological monitoring
EP2433667A1 (en) * 2010-09-28 2012-03-28 Koninklijke Philips Electronics N.V. Breath pacing apparatus, and method for pacing the respiration of a person
US20120083648A1 (en) * 2010-10-04 2012-04-05 S.C. Johnson & Son, Inc. Apparatus and Method for Relieving Stress
WO2012061707A2 (en) * 2010-11-04 2012-05-10 The Cleveland Clinic Foundation Handheld biofeedback device and method for self-regulating at least one physiological state of a subject
CN103209635B (en) 2010-11-23 2016-08-10 皇家飞利浦电子股份有限公司 For the respiratory activity of object being carried out the breathing pacing system and method for pacing
BR112013012431A2 (en) 2010-11-23 2019-09-24 Koninl Philips Electronics Nv "breath stimulation device to stimulate an individual's respiratory activity"
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US9311825B2 (en) 2011-12-22 2016-04-12 Senstream, Inc. Biometric sensing and processing apparatus for mobile gaming, education, and wellness applications
KR101184684B1 (en) * 2012-02-15 2012-09-20 (주)트라이스 Respiration training method and apparatus for real-time recognition of correct respiring state
US10632040B2 (en) 2012-02-29 2020-04-28 Frederick Muench Systems, devices, components and methods for triggering or inducing resonance or high amplitude oscillations in a cardiovascular system of a patient
US9943461B1 (en) 2012-02-29 2018-04-17 Frederick Muench Systems, devices, components and methods for triggering or inducing resonance or high amplitude oscillations in a cardiovascular system of a patient
US10973736B2 (en) 2012-02-29 2021-04-13 Frederick J. Muench Systems, devices, components and methods for triggering or inducing resonance or high amplitude oscillations in a cardiovascular system of a patient
US10098810B1 (en) 2013-02-27 2018-10-16 Frederick Muench Systems, devices, components and methods for triggering or inducing resonance or high amplitude oscillations in a cardiovascular system of a patient
US9993604B2 (en) 2012-04-27 2018-06-12 Covidien Lp Methods and systems for an optimized proportional assist ventilation
US9339193B2 (en) * 2012-05-21 2016-05-17 Fujitsu Limited Physiological adaptability system with multiple sensors
US9814438B2 (en) 2012-06-18 2017-11-14 Breath Research, Inc. Methods and apparatus for performing dynamic respiratory classification and tracking
US10426426B2 (en) 2012-06-18 2019-10-01 Breathresearch, Inc. Methods and apparatus for performing dynamic respiratory classification and tracking
KR101244730B1 (en) * 2012-07-11 2013-03-18 (주)트라이스 Respiration training apparatus for real-time recognition of correct respiring state
US9375542B2 (en) 2012-11-08 2016-06-28 Covidien Lp Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation
US9358355B2 (en) 2013-03-11 2016-06-07 Covidien Lp Methods and systems for managing a patient move
JP6149450B2 (en) * 2013-03-21 2017-06-21 富士通株式会社 Respiratory information estimation apparatus and method, and program
CN104367311A (en) * 2013-09-09 2015-02-25 北京优瀚康科技有限公司 Intelligent breath regulator
CN104667487A (en) * 2015-01-26 2015-06-03 周常安 Biofeedback system
CN104667486A (en) * 2015-01-26 2015-06-03 周常安 Biofeedback system
US10905836B2 (en) 2015-04-02 2021-02-02 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
JP2017035327A (en) * 2015-08-11 2017-02-16 セイコーエプソン株式会社 Exercise support device, exercise support system, exercise support method and exercise support program
US10517531B2 (en) 2016-02-08 2019-12-31 Vardas Solutions LLC Stress management using biofeedback
US10398350B2 (en) * 2016-02-08 2019-09-03 Vardas Solutions LLC Methods and systems for providing a breathing rate calibrated to a resonance breathing frequency
CN105852884B (en) * 2016-03-22 2019-01-29 清华大学 A kind of cognition load and pressure measurement method and device based on peripheral vessels strain
JP6479720B2 (en) * 2016-08-30 2019-03-06 株式会社電通 Meditation assistance device and meditation assistance system
JP6930546B2 (en) * 2016-11-30 2021-09-01 ソニーグループ株式会社 Output control device, output control method and program
GB2567678A (en) * 2017-10-20 2019-04-24 Bournemouth Univ Higher Education Corporation Device and method for guiding breathing of a user
KR102183435B1 (en) 2017-11-13 2020-11-27 사회복지법인 삼성생명공익재단 An user stress relieving method and system using virtual reality and biofeedback
CN110049799B (en) 2017-11-14 2022-04-26 柯惠有限合伙公司 Method and system for driving pressure spontaneous ventilation
WO2019110407A1 (en) * 2017-12-06 2019-06-13 Resilio Aps A computer implemented method for breathing exercises
US10896754B2 (en) * 2018-01-04 2021-01-19 Cardiac Pacemakers, Inc. Troubleshooting system for remote patient monitoring
JP7141680B2 (en) * 2018-01-29 2022-09-26 株式会社Agama-X Information processing device, information processing system and program
JP7141681B2 (en) * 2018-01-29 2022-09-26 株式会社Agama-X Information processing device, information processing system and program
WO2019240778A1 (en) * 2018-06-12 2019-12-19 Vardas Solutions LLC Methods and systems for providing a breathing rate calibrated to a resonance frequency
US11517691B2 (en) 2018-09-07 2022-12-06 Covidien Lp Methods and systems for high pressure controlled ventilation
US20200253507A1 (en) 2019-02-13 2020-08-13 Vardas Solutions LLC Measuring user respiration at extremities
US20220202312A1 (en) * 2020-12-30 2022-06-30 Auralab Technologies Incorporated Respiratory Biofeedback-Based Content Selection and Playback for Guided Sessions and Device Adjustments
DE102022114277A1 (en) 2022-06-07 2023-12-07 BioSign Medical UG (haftungsbeschränkt) Method, device and executable computer program for the individualized quantification of a respiratory sinus arrhythmia

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2020402A (en) * 1933-05-04 1935-11-12 American Telephone & Telegraph Test pick
US4420000A (en) * 1981-09-28 1983-12-13 Camino Laboratories, Inc. Method and apparatus for measuring heartbeat rate
US4519395A (en) 1982-12-15 1985-05-28 Hrushesky William J M Medical instrument for noninvasive measurement of cardiovascular characteristics
US4510944A (en) 1982-12-30 1985-04-16 Porges Stephen W Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems
US4960129A (en) 1988-12-05 1990-10-02 Trustees Of The University Of Pennsylvania Methods of observing autonomic neural stimulation and diagnosing cardiac dynamical dysfunction using heartbeat interval data to analyze cardioventilatory interactions
US5265617A (en) 1991-02-20 1993-11-30 Georgetown University Methods and means for non-invasive, dynamic tracking of cardiac vulnerability by simultaneous analysis of heart rate variability and T-wave alternans
US5148812A (en) 1991-02-20 1992-09-22 Georgetown University Non-invasive dynamic tracking of cardiac vulnerability by analysis of t-wave alternans
US5277189A (en) 1991-08-16 1994-01-11 Nid, Inc. Method and apparatus for the measurement and analysis of cardiac rates and amplitude variations
US5520192A (en) 1991-12-23 1996-05-28 Imperial College Of Science, Technology And Medicine Apparatus for the monitoring and control of respiration
US5291400A (en) 1992-04-09 1994-03-01 Spacelabs Medical, Inc. System for heart rate variability analysis
US5891044A (en) 1992-10-06 1999-04-06 Gw Scientific, Inc. Detection of abnormal and induction of normal heart rate variability
US5718235A (en) 1992-10-06 1998-02-17 Gw Scientific, Inc. Detection of abnormal and induction of normal heart rate variability
US5423325A (en) 1993-03-12 1995-06-13 Hewlett-Packard Corporation Methods for enhancement of HRV and late potentials measurements
WO1995003739A1 (en) 1993-08-03 1995-02-09 Peter Walter Kamen A method of measuring autonomic activity of a patient
US5687734A (en) 1994-10-20 1997-11-18 Hewlett-Packard Company Flexible patient monitoring system featuring a multiport transmitter
US5579775A (en) 1994-10-20 1996-12-03 Hewlett-Packard Company Dynamic control of a patient monitoring system
US5853364A (en) 1995-08-07 1998-12-29 Nellcor Puritan Bennett, Inc. Method and apparatus for estimating physiological parameters using model-based adaptive filtering
US5807247A (en) 1995-12-20 1998-09-15 Nellcor Puritan Bennett Incorporated Method and apparatus for facilitating compatibility between pulse oximeters and sensor probes
US5603331A (en) 1996-02-12 1997-02-18 Cardiac Pacemakers, Inc. Data logging system for implantable cardiac device
US6002952A (en) 1997-04-14 1999-12-14 Masimo Corporation Signal processing apparatus and method
US6106481A (en) 1997-10-01 2000-08-22 Boston Medical Technologies, Inc. Method and apparatus for enhancing patient compliance during inspiration measurements
US6099481A (en) 1997-11-03 2000-08-08 Ntc Technology, Inc. Respiratory profile parameter determination method and apparatus
US6539249B1 (en) 1998-05-11 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for assessing patient well-being
US5997482A (en) 1998-06-01 1999-12-07 Vaschillo; Evgeny G. Therapeutic method for a human subject
US6301499B1 (en) 1998-06-08 2001-10-09 Cardiac Pacemakers, Inc. Heart rate variability as an indicator of exercise capacity
US6026320A (en) 1998-06-08 2000-02-15 Cardiac Pacemakers, Inc. Heart rate variability as an indicator of exercise capacity
US6144877A (en) 1998-08-11 2000-11-07 The United States Of America As Represented By The Department Of Health And Human Services Determining the hurst exponent for time series data
US20040230252A1 (en) 1998-10-21 2004-11-18 Saul Kullok Method and apparatus for affecting the autonomic nervous system
JP2000166889A (en) 1998-12-11 2000-06-20 Inst Of Physical & Chemical Res Heart rate fluctuation estimation method and device thereof
US6658276B2 (en) 1999-01-25 2003-12-02 Masimo Corporation Pulse oximeter user interface
US6305943B1 (en) * 1999-01-29 2001-10-23 Biomed Usa, Inc. Respiratory sinus arrhythmia training system
US6212427B1 (en) 1999-02-02 2001-04-03 J&J Engineering Heart rate variability feedback monitor system
US20050033189A1 (en) 2003-08-08 2005-02-10 Mccraty Rollin I. Electrophysiological intuition indicator
US6358201B1 (en) * 1999-03-02 2002-03-19 Doc L. Childre Method and apparatus for facilitating physiological coherence and autonomic balance
US6490480B1 (en) 1999-09-16 2002-12-03 Eduard Lerner Apparatus and methods for measuring autonomic nervous system function
US6678547B2 (en) 2001-03-08 2004-01-13 Cardiac Pacemakers, Inc. Cardiac rhythm management system using time-domain heart rate variability indicia
IL134123A (en) 2000-01-19 2005-06-19 Lev El Diagnostics Of Heart Di Method and system for measuring heart rate variability
DE10006154A1 (en) 2000-02-11 2001-08-16 Biotronik Mess & Therapieg Process for calculating the heart rate variability for use in an EKG monitor and EKG monitor with a corresponding calculation program
US6487442B1 (en) 2000-04-28 2002-11-26 Nicholas Wood Detection of abnormal and induction of normal heat rate variability
JP2003534044A (en) 2000-05-13 2003-11-18 オメガウエーブ エルエルシー Apparatus and method for non-invasively measuring functional state and adaptive response of human body
US6416473B1 (en) 2000-06-13 2002-07-09 Boston Medical Technologies, Inc. Methods and apparatus for providing an indicator of autonomic nervous system function
JP2002112969A (en) 2000-09-02 2002-04-16 Samsung Electronics Co Ltd Device and method for recognizing physical and emotional conditions
US6836681B2 (en) 2001-02-15 2004-12-28 Jon R. Stabler Method of reducing stress
DK1397167T3 (en) 2001-05-09 2010-06-07 Biointeractions Ltd Wound closure system as well as procedure
US6626843B2 (en) * 2001-09-28 2003-09-30 Deane Hillsman Respiratory timing and lung deflation method and device
US6805673B2 (en) 2002-02-22 2004-10-19 Datex-Ohmeda, Inc. Monitoring mayer wave effects based on a photoplethysmographic signal
US6702752B2 (en) 2002-02-22 2004-03-09 Datex-Ohmeda, Inc. Monitoring respiration based on plethysmographic heart rate signal
JP2005535359A (en) 2002-02-22 2005-11-24 デイテックス−オーメダ インコーポレイテッド Monitoring physiological parameters based on fluctuations in photoplethysmographic signals
US6896661B2 (en) 2002-02-22 2005-05-24 Datex-Ohmeda, Inc. Monitoring physiological parameters based on variations in a photoplethysmographic baseline signal
AU2003217878A1 (en) 2002-03-01 2003-09-16 Christine Ross Novel utilization of heart rate variability in animals
US20040122487A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with composite parameter indices
US20040122486A1 (en) * 2002-12-18 2004-06-24 Stahmann Jeffrey E. Advanced patient management for acquiring, trending and displaying health-related parameters
US6850788B2 (en) 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US7343199B2 (en) 2002-12-27 2008-03-11 Cardiac Pacemakers, Inc. Measurement of respiratory sinus arrhythmia using respiratory and electrogram sensors in an implantable device
KR100519758B1 (en) * 2003-01-22 2005-10-07 삼성전자주식회사 Method and apparatus for evaluating human stress using PPG
JP3966833B2 (en) 2003-05-12 2007-08-29 パイオニア株式会社 Biological information detection device
JP4331977B2 (en) 2003-05-21 2009-09-16 パイオニア株式会社 Mental state determination device and mental state determination method
US20040249299A1 (en) 2003-06-06 2004-12-09 Cobb Jeffrey Lane Methods and systems for analysis of physiological signals
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system

Also Published As

Publication number Publication date
EP1729845A4 (en) 2008-04-02
US20050288601A1 (en) 2005-12-29
KR101224346B1 (en) 2013-01-21
EP1729845B1 (en) 2017-02-22
EP1729845A1 (en) 2006-12-13
WO2005089856A1 (en) 2005-09-29
AU2005222712A1 (en) 2005-09-29
BRPI0508896A (en) 2007-09-11
CN1968727A (en) 2007-05-23
KR20070026460A (en) 2007-03-08
ZA200607757B (en) 2008-05-28
US7691049B2 (en) 2010-04-06
US8938288B2 (en) 2015-01-20
JP2007529283A (en) 2007-10-25
US20100174200A1 (en) 2010-07-08
CA2560294C (en) 2014-05-27
CN1968727B (en) 2010-12-22
MXPA06010498A (en) 2007-03-28

Similar Documents

Publication Publication Date Title
CA2560294C (en) Methods and devices for relieving stress
US8428702B2 (en) Methods and devices for relieving stress
CA2604741C (en) Methods and devices for relieving stress
US9265430B2 (en) Method, system and software product for the measurement of heart rate variability
US20230277800A1 (en) Sleep performance system and method of use
US11793448B2 (en) Detection device
Jovanov On spectral analysis of heart rate variability during very slow yogic breathing
Vaschillo et al. The effects of sighing on the cardiovascular system
CN101203175B (en) Methods and devices for relieving stress
Suma et al. Pulse Rate Variability for Detection of Autonomic Tone of an Individual
Weinstein et al. Influence of control and physical effort on cardiovascular reactivity to a video game task
WO2023078535A1 (en) System and method for monitoring a physiological state of a user and providing at least one personalized breathing exercise to the user, and virtual monitoring program for executing the method
Beauchamp Thought Technology Ltd.
WO2022219236A1 (en) System, method and computer program for monitoring health of a person
Hwang et al. Optimized exercise load control system based on heart rate variability
Iacono Heart rate and sensorimotor performance
Sakaguchi et al. Control of heart rate variability by cardiac
UA70135C2 (en) Method for determination of breath influence on spectrogram of heart rate

Legal Events

Date Code Title Description
EEER Examination request